HEADER TRANSFERASE 15-APR-09 2WFY TITLE TRUNCATION AND OPTIMISATION OF PEPTIDE INHIBITORS OF CDK2, CYCLIN A TITLE 2 THROUGH STRUCTURE GUIDED DESIGN COMPND MOL_ID: 1; COMPND 2 MOLECULE: CELL DIVISION PROTEIN KINASE 2; COMPND 3 CHAIN: A, C; COMPND 4 SYNONYM: CYCLIN-DEPENDENT KINASE 2, P33 PROTEIN KINASE; COMPND 5 EC: 2.7.1.37; COMPND 6 ENGINEERED: YES; COMPND 7 MOL_ID: 2; COMPND 8 MOLECULE: CYCLIN-A2; COMPND 9 CHAIN: B, D; COMPND 10 FRAGMENT: RESIDUES 173-432; COMPND 11 SYNONYM: CYCLIN-A; COMPND 12 ENGINEERED: YES; COMPND 13 MOL_ID: 3; COMPND 14 MOLECULE: ARG-ARG-B3L-PHE; COMPND 15 CHAIN: E, F; COMPND 16 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 EXPRESSION_SYSTEM: SPODOPTERA FRUGIPERDA; SOURCE 6 EXPRESSION_SYSTEM_COMMON: FALL ARMYWORM; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 7108; SOURCE 8 EXPRESSION_SYSTEM_CELL_LINE: SF9; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: BACULOVIRUS; SOURCE 10 MOL_ID: 2; SOURCE 11 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 12 ORGANISM_COMMON: HUMAN; SOURCE 13 ORGANISM_TAXID: 9606; SOURCE 14 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 15 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 16 MOL_ID: 3; SOURCE 17 SYNTHETIC: YES; SOURCE 18 ORGANISM_SCIENTIFIC: SYNTHETIC CONSTRUCT; SOURCE 19 ORGANISM_TAXID: 32630 KEYWDS CDK2, KINASE, CYCLIN, ACTIVE, NUCLEUS, MITOSIS, SERINE/THREONINE- KEYWDS 2 PROTEIN KINASE, CYTOPLASM, INHIBITION, CELL CYCLE, ATP-BINDING, CELL KEYWDS 3 DIVISION, PHOSPHOPROTEIN, NUCLEOTIDE-BINDING, TRANSFERASE, KEYWDS 4 POLYMORPHISM, BETA-PEPTIDE, CYCLIN GROOVE EXPDTA X-RAY DIFFRACTION AUTHOR G.KONTOPIDIS,M.J.ANDREWS,C.MCINNES,A.PLATER,L.INNES,S.RENACHOWSKI, AUTHOR 2 A.COWAN,P.M.FISCHER REVDAT 5 13-DEC-23 2WFY 1 REMARK REVDAT 4 15-NOV-23 2WFY 1 LINK ATOM REVDAT 3 28-DEC-16 2WFY 1 SOURCE REMARK SITE REVDAT 2 12-OCT-11 2WFY 1 JRNL REMARK HETSYN FORMUL REVDAT 2 2 1 VERSN REVDAT 1 09-JUN-09 2WFY 0 JRNL AUTH G.KONTOPIDIS,M.J.ANDREWS,C.MCINNES,A.PLATER,L.INNES, JRNL AUTH 2 S.RENACHOWSKI,A.COWAN,P.M.FISCHER JRNL TITL TRUNCATION AND OPTIMISATION OF PEPTIDE INHIBITORS OF JRNL TITL 2 CYCLIN-DEPENDENT KINASE 2-CYCLIN A THROUGH STRUCTURE-GUIDED JRNL TITL 3 DESIGN. JRNL REF CHEMMEDCHEM V. 4 1120 2009 JRNL REFN ISSN 1860-7179 JRNL PMID 19472269 JRNL DOI 10.1002/CMDC.200900093 REMARK 2 REMARK 2 RESOLUTION. 2.53 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.2.0019 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.53 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 40.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 92.2 REMARK 3 NUMBER OF REFLECTIONS : 41853 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.195 REMARK 3 R VALUE (WORKING SET) : 0.193 REMARK 3 FREE R VALUE : 0.259 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 2.100 REMARK 3 FREE R VALUE TEST SET COUNT : 880 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.53 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.60 REMARK 3 REFLECTION IN BIN (WORKING SET) : 2615 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 78.36 REMARK 3 BIN R VALUE (WORKING SET) : 0.3970 REMARK 3 BIN FREE R VALUE SET COUNT : 43 REMARK 3 BIN FREE R VALUE : 0.5410 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 9017 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 0 REMARK 3 SOLVENT ATOMS : 443 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 52.65 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -3.49000 REMARK 3 B22 (A**2) : 1.00000 REMARK 3 B33 (A**2) : 2.49000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.785 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.323 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.252 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 11.747 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.954 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.914 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 9263 ; 0.013 ; 0.022 REMARK 3 BOND LENGTHS OTHERS (A): NULL ; NULL ; NULL REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 12577 ; 1.608 ; 1.984 REMARK 3 BOND ANGLES OTHERS (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 1110 ; 6.764 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 398 ;41.514 ;23.995 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 1619 ;20.113 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 44 ;22.410 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 1421 ; 0.114 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 6896 ; 0.005 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): 4288 ; 0.244 ; 0.300 REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): 6376 ; 0.327 ; 0.500 REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): 657 ; 0.195 ; 0.500 REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): 45 ; 0.226 ; 0.300 REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): 10 ; 0.161 ; 0.500 REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 5686 ; 1.411 ; 1.500 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 9051 ; 2.262 ; 2.000 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 3933 ; 3.692 ; 3.000 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 3523 ; 5.578 ; 4.500 REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : 2 REMARK 3 REMARK 3 NCS GROUP NUMBER : 1 REMARK 3 CHAIN NAMES : A C REMARK 3 NUMBER OF COMPONENTS NCS GROUP : 1 REMARK 3 COMPONENT C SSSEQI TO C SSSEQI CODE REMARK 3 1 A 1 A 296 3 REMARK 3 1 C 1 C 296 3 REMARK 3 GROUP CHAIN COUNT RMS WEIGHT REMARK 3 TIGHT POSITIONAL 1 A (A): 1179 ; 0.15 ; 0.05 REMARK 3 TIGHT POSITIONAL 1 C (A): 1179 ; 0.15 ; 0.05 REMARK 3 LOOSE POSITIONAL 1 A (A): 1179 ; 0.54 ; 5.00 REMARK 3 LOOSE POSITIONAL 1 C (A): 1179 ; 0.54 ; 5.00 REMARK 3 TIGHT THERMAL 1 A (A**2): 1179 ; 0.41 ; 0.50 REMARK 3 TIGHT THERMAL 1 C (A**2): 1179 ; 0.41 ; 0.50 REMARK 3 LOOSE THERMAL 1 A (A**2): 1179 ; 2.88 ; 10.00 REMARK 3 LOOSE THERMAL 1 C (A**2): 1179 ; 2.88 ; 10.00 REMARK 3 REMARK 3 NCS GROUP NUMBER : 2 REMARK 3 CHAIN NAMES : B D REMARK 3 NUMBER OF COMPONENTS NCS GROUP : 1 REMARK 3 COMPONENT C SSSEQI TO C SSSEQI CODE REMARK 3 1 B 176 B 432 2 REMARK 3 1 D 176 D 432 2 REMARK 3 GROUP CHAIN COUNT RMS WEIGHT REMARK 3 TIGHT POSITIONAL 2 B (A): 1026 ; 0.08 ; 0.05 REMARK 3 TIGHT POSITIONAL 2 D (A): 1026 ; 0.08 ; 0.05 REMARK 3 MEDIUM POSITIONAL 2 B (A): 1044 ; 0.44 ; 0.50 REMARK 3 MEDIUM POSITIONAL 2 D (A): 1044 ; 0.44 ; 0.50 REMARK 3 TIGHT THERMAL 2 B (A**2): 1026 ; 0.55 ; 0.50 REMARK 3 TIGHT THERMAL 2 D (A**2): 1026 ; 0.55 ; 0.50 REMARK 3 MEDIUM THERMAL 2 B (A**2): 1044 ; 1.36 ; 2.00 REMARK 3 MEDIUM THERMAL 2 D (A**2): 1044 ; 1.36 ; 2.00 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS. RESIDUES 36-40 IN CHAIN A AND C ARE DISORDERED REMARK 3 RESIDUES 323-325 IN CHAIN B NAD D ARE DISORDERED REMARK 4 REMARK 4 2WFY COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 15-APR-09. REMARK 100 THE DEPOSITION ID IS D_1290039476. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : NULL REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.8 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SRS REMARK 200 BEAMLINE : PX14.1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.977 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : MIRRORS REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC CCD REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 46387 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.530 REMARK 200 RESOLUTION RANGE LOW (A) : 40.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 1.300 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 80.0 REMARK 200 DATA REDUNDANCY : 13.00 REMARK 200 R MERGE (I) : 0.30000 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 9.0000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.53 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.56 REMARK 200 COMPLETENESS FOR SHELL (%) : 70.0 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : 0.30000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 1.340 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: MOLREP REMARK 200 STARTING MODEL: PDB ENTRY 1OKV REMARK 200 REMARK 200 REMARK: NONE REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 50.02 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.48 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PEG3350 30% V/V, 0.1M TRI-SODIUM REMARK 280 CITRATE, PH 7.8 REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 37.31050 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 78.95550 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 57.90650 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 78.95550 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 37.31050 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 57.90650 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TRIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TRIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 4430 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 24120 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -17.9 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, E REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TRIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TRIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 4430 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 24570 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -12.9 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: C, D, F REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 ARG A 297 REMARK 465 LEU A 298 REMARK 465 ASN B 173 REMARK 465 GLU B 174 REMARK 465 VAL B 175 REMARK 465 LEU C 298 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 LEU A 296 CA C O CB CG CD1 CD2 REMARK 470 ARG C 297 CA C O CB CG CD NE REMARK 470 ARG C 297 CZ NH1 NH2 REMARK 470 LEU D 432 O REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 OE1 GLU A 57 NH2 ARG A 122 2.14 REMARK 500 OE2 GLU A 224 OG1 THR A 231 2.15 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND LENGTHS REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,2(A3,1X,A1,I4,A1,1X,A4,3X),1X,F6.3) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 RES CSSEQI ATM2 DEVIATION REMARK 500 ASN D 173 C GLU D 174 N 0.287 REMARK 500 ARG E 2 CB ARG E 2 CG -0.185 REMARK 500 ARG E 3 CB ARG E 3 CG -0.188 REMARK 500 ARG F 2 CB ARG F 2 CG -0.192 REMARK 500 ARG F 3 CB ARG F 3 CG -0.202 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 B3L E 4 CA - C - N ANGL. DEV. = 33.3 DEGREES REMARK 500 B3L F 4 CA - C - N ANGL. DEV. = 30.1 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASP A 38 109.26 -53.83 REMARK 500 THR A 41 -111.85 -97.11 REMARK 500 LEU A 96 -63.09 97.75 REMARK 500 ARG A 126 -25.86 88.77 REMARK 500 ASP A 145 74.14 62.42 REMARK 500 THR A 165 114.18 36.75 REMARK 500 ARG A 199 7.56 82.89 REMARK 500 LYS A 242 72.69 -103.77 REMARK 500 ARG A 245 119.28 -37.53 REMARK 500 ASP B 283 47.32 72.59 REMARK 500 TRP B 372 99.47 -27.95 REMARK 500 HIS B 419 19.80 54.64 REMARK 500 ASN B 431 30.63 74.89 REMARK 500 THR C 41 -130.24 -91.02 REMARK 500 LEU C 96 -56.98 95.95 REMARK 500 ARG C 126 -12.77 84.65 REMARK 500 ASP C 127 58.55 -149.68 REMARK 500 ASP C 145 73.10 59.71 REMARK 500 HIS C 161 74.00 77.01 REMARK 500 LYS C 242 77.54 -104.25 REMARK 500 PRO C 254 19.64 -69.49 REMARK 500 GLU D 174 48.77 74.73 REMARK 500 VAL D 197 -76.13 -61.49 REMARK 500 ASP D 283 43.60 79.28 REMARK 500 ASP D 284 51.13 26.40 REMARK 500 THR D 368 -20.63 -142.49 REMARK 500 TRP D 372 108.37 -32.87 REMARK 500 LEU D 384 -37.72 -39.12 REMARK 500 ASN D 431 28.29 80.84 REMARK 500 B3L E 4 -55.46 -121.61 REMARK 500 B3L F 4 -85.26 -96.65 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: NON-CIS, NON-TRANS REMARK 500 REMARK 500 THE FOLLOWING PEPTIDE BONDS DEVIATE SIGNIFICANTLY FROM BOTH REMARK 500 CIS AND TRANS CONFORMATION. CIS BONDS, IF ANY, ARE LISTED REMARK 500 ON CISPEP RECORDS. TRANS IS DEFINED AS 180 +/- 30 AND REMARK 500 CIS IS DEFINED AS 0 +/- 30 DEGREES. REMARK 500 MODEL OMEGA REMARK 500 B3L E 4 PHE E 5 -94.97 REMARK 500 B3L F 4 PHE F 5 -86.91 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: PLANAR GROUPS REMARK 500 REMARK 500 PLANAR GROUPS IN THE FOLLOWING RESIDUES HAVE A TOTAL REMARK 500 RMS DISTANCE OF ALL ATOMS FROM THE BEST-FIT PLANE REMARK 500 BY MORE THAN AN EXPECTED VALUE OF 6*RMSD, WITH AN REMARK 500 RMSD 0.02 ANGSTROMS, OR AT LEAST ONE ATOM HAS REMARK 500 AN RMSD GREATER THAN THIS VALUE REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 M RES CSSEQI RMS TYPE REMARK 500 ARG E 2 0.29 SIDE CHAIN REMARK 500 ARG E 3 0.15 SIDE CHAIN REMARK 500 ARG F 2 0.27 SIDE CHAIN REMARK 500 ARG F 3 0.28 SIDE CHAIN REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: MAIN CHAIN PLANARITY REMARK 500 REMARK 500 THE FOLLOWING RESIDUES HAVE A PSEUDO PLANARITY REMARK 500 TORSION ANGLE, C(I) - CA(I) - N(I+1) - O(I), GREATER REMARK 500 10.0 DEGREES. (M=MODEL NUMBER; RES=RESIDUE NAME; REMARK 500 C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 500 I=INSERTION CODE). REMARK 500 REMARK 500 M RES CSSEQI ANGLE REMARK 500 B3L F 4 18.15 REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH A2004 DISTANCE = 7.21 ANGSTROMS REMARK 525 HOH D2001 DISTANCE = 5.91 ANGSTROMS REMARK 525 HOH D2004 DISTANCE = 6.90 ANGSTROMS REMARK 600 REMARK 600 HETEROGEN REMARK 600 REMARK 600 CHAINS E AND F COULD BE REPRESENTED AS A SINGLE HETEROGEN REMARK 600 WITH NAME: REMARK 600 (S)-3-((S)-2-((S)-2-ACETAMIDO-5-GUANIDINOPENTANAMIDO)- REMARK 600 5-GUANIDINOPENTANAMIDO)-N-((S)-1-AMINO-1-OXO-3- REMARK 600 PHENYLPROPAN-2-YL)-5-METHYLHEXANAMIDE REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR CHAIN E OF ARG-ARG-B3L-PHE REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR CHAIN F OF ARG-ARG-B3L-PHE REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1H08 RELATED DB: PDB REMARK 900 CDK2 IN COMPLEX WITH A DISUBSTITUTED 2, 4 -BIS ANILINO PYRIMIDINE REMARK 900 CDK4 INHIBITOR REMARK 900 RELATED ID: 1PYE RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF CDK2 WITH INHIBITOR REMARK 900 RELATED ID: 2VTH RELATED DB: PDB REMARK 900 IDENTIFICATION OF N-(4-PIPERIDINYL)-4-(2,6 -DICHLOROBENZOYLAMINO)- REMARK 900 1H-PYRAZOLE-3- CARBOXAMIDE (AT7519), A NOVEL CYCLIN DEPENDENT REMARK 900 KINASE INHIBITOR USING FRAGMENT-BASED X- RAY CRYSTALLOGRAPHY AND REMARK 900 STRUCTURE BASED DRUG DESIGN. REMARK 900 RELATED ID: 2B53 RELATED DB: PDB REMARK 900 HUMAN CYCLIN DEPENDENT KINASE 2 (CDK2) COMPLEXED WITH DIN-234325 REMARK 900 RELATED ID: 1V1K RELATED DB: PDB REMARK 900 CDK2 IN COMPLEX WITH A DISUBSTITUTED 4, 6 -BIS ANILINO PYRIMIDINE REMARK 900 CDK4 INHIBITOR REMARK 900 RELATED ID: 1KE7 RELATED DB: PDB REMARK 900 CYCLIN-DEPENDENT KINASE 2 (CDK2) COMPLEXED WITH 3-{[(2,2-DIOXIDO-1, REMARK 900 3-DIHYDRO-2- BENZOTHIEN-5-YL)AMINO]METHYLENE}-5-(1,3- OXAZOL-5-YL)- REMARK 900 1,3-DIHYDRO-2H-INDOL-2- ONE REMARK 900 RELATED ID: 1OKV RELATED DB: PDB REMARK 900 CYCLIN A BINDING GROOVE INHIBITOR H-ARG- ARG-LEU-ILE-PHE-NH2 REMARK 900 RELATED ID: 1H25 RELATED DB: PDB REMARK 900 CDK2/CYCLINA IN COMPLEX WITH AN 11-RESIDUE RECRUITMENT PEPTIDE FROM REMARK 900 E2F REMARK 900 RELATED ID: 1PXK RELATED DB: PDB REMARK 900 HUMAN CYCLIN DEPENDENT KINASE 2 COMPLEXED WITH THEINHIBITOR N-[4-(2, REMARK 900 4-DIMETHYL- THIAZOL-5-YL)PYRIMIDIN-2-YL]-N'- HYDROXYIMINOFORMAMIDE REMARK 900 RELATED ID: 2BHH RELATED DB: PDB REMARK 900 HUMAN CYCLIN DEPENDENT PROTEIN KINASE 2 IN COMPLEX WITH THE REMARK 900 INHIBITOR 4- HYDROXYPIPERINDINESULFONYL-INDIRUBINE REMARK 900 RELATED ID: 2VTA RELATED DB: PDB REMARK 900 IDENTIFICATION OF N-(4-PIPERIDINYL)-4-(2,6 -DICHLOROBENZOYLAMINO)- REMARK 900 1H-PYRAZOLE-3- CARBOXAMIDE (AT7519), A NOVEL CYCLIN DEPENDENT REMARK 900 KINASE INHIBITOR USING FRAGMENT-BASED X- RAY CRYSTALLOGRAPHY AND REMARK 900 STRUCTURE BASED DRUG DESIGN. REMARK 900 RELATED ID: 2UUE RELATED DB: PDB REMARK 900 REPLACE: A STRATEGY FOR ITERATIVE DESIGN OF CYCLIN BINDING GROOVE REMARK 900 INHIBITORS REMARK 900 RELATED ID: 1GZ8 RELATED DB: PDB REMARK 900 HUMAN CYCLIN DEPENDENT KINASE 2 COMPLEXED WITH THE INHIBITOR 2- REMARK 900 AMINO-6-(3'-METHYL- 2'-OXO)BUTOXYPURINE REMARK 900 RELATED ID: 1E1V RELATED DB: PDB REMARK 900 HUMAN CYCLIN DEPENDENT KINASE 2 COMPLEXED WITH THE INHIBITOR NU2058 REMARK 900 RELATED ID: 1OL2 RELATED DB: PDB REMARK 900 CYCLIN A BINDING GROOVE INHIBITOR H-ARG- ARG-LEU-ASN-(P-F-PHE)-NH2 REMARK 900 RELATED ID: 1H27 RELATED DB: PDB REMARK 900 CDK2/CYCLINA IN COMPLEX WITH AN 11-RESIDUE RECRUITMENT PEPTIDE FROM REMARK 900 P27 REMARK 900 RELATED ID: 1JSV RELATED DB: PDB REMARK 900 THE STRUCTURE OF CYCLIN-DEPENDENT KINASE 2 (CDK2) INCOMPLEX WITH 4- REMARK 900 [(6-AMINO-4- PYRIMIDINYL)AMINO]BENZENESULFONAMIDE REMARK 900 RELATED ID: 2B52 RELATED DB: PDB REMARK 900 HUMAN CYCLIN DEPENDENT KINASE 2 (CDK2) COMPLEXED WITH DPH-042562 REMARK 900 RELATED ID: 1KE5 RELATED DB: PDB REMARK 900 CDK2 COMPLEXED WITH N-METHYL-4-{[(2-OXO- 1,2-DIHYDRO-3H-INDOL-3- REMARK 900 YLIDENE)METHYL] AMINO}BENZENESULFONAMIDE REMARK 900 RELATED ID: 1FIN RELATED DB: PDB REMARK 900 CYCLIN A - CYCLIN-DEPENDENT KINASE 2 COMPLEX REMARK 900 RELATED ID: 2C5O RELATED DB: PDB REMARK 900 DIFFERENTIAL BINDING OF INHIBITORS TO ACTIVE AND INACTIVE CDK2 REMARK 900 PROVIDES INSIGHTS FOR DRUG DESIGN REMARK 900 RELATED ID: 2C68 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE HUMAN CDK2 COMPLEXED WITH THE REMARK 900 TRIAZOLOPYRIMIDINE INHIBITOR REMARK 900 RELATED ID: 2VTT RELATED DB: PDB REMARK 900 IDENTIFICATION OF N-(4-PIPERIDINYL)-4-(2,6 -DICHLOROBENZOYLAMINO)- REMARK 900 1H-PYRAZOLE-3- CARBOXAMIDE (AT7519), A NOVEL CYCLIN DEPENDENT REMARK 900 KINASE INHIBITOR USING FRAGMENT-BASED X- RAY CRYSTALLOGRAPHY AND REMARK 900 STRUCTURE BASED DRUG DESIGN. REMARK 900 RELATED ID: 1P2A RELATED DB: PDB REMARK 900 THE STRUCTURE OF CYCLIN DEPENDENT KINASE 2 (CKD2) WITH REMARK 900 ATRISUBSTITUTED NAPHTHOSTYRIL INHIBITOR REMARK 900 RELATED ID: 2VTQ RELATED DB: PDB REMARK 900 IDENTIFICATION OF N-(4-PIPERIDINYL)-4-(2,6 -DICHLOROBENZOYLAMINO)- REMARK 900 1H-PYRAZOLE-3- CARBOXAMIDE (AT7519), A NOVEL CYCLIN DEPENDENT REMARK 900 KINASE INHIBITOR USING FRAGMENT-BASED X- RAY CRYSTALLOGRAPHY AND REMARK 900 STRUCTURE BASED DRUG DESIGN. REMARK 900 RELATED ID: 2C4G RELATED DB: PDB REMARK 900 STRUCTURE OF CDK2-CYCLIN A WITH PHA-533514 REMARK 900 RELATED ID: 1H1Q RELATED DB: PDB REMARK 900 STRUCTURE OF HUMAN THR160-PHOSPHO CDK2/ CYCLIN A COMPLEXED WITH THE REMARK 900 INHIBITOR NU6094 REMARK 900 RELATED ID: 1W0X RELATED DB: PDB REMARK 900 CRYSTALS STRUCTURE OF HUMAN CDK2 IN COMPLEX WITH THE INHIBITOR REMARK 900 OLOMOUCINE. REMARK 900 RELATED ID: 2W05 RELATED DB: PDB REMARK 900 STRUCTURE OF CDK2 IN COMPLEX WITH AN IMIDAZOLYL PYRIMIDINE, REMARK 900 COMPOUND 5B REMARK 900 RELATED ID: 1PXO RELATED DB: PDB REMARK 900 HUMAN CYCLIN DEPENDENT KINASE 2 COMPLEXED WITH THEINHIBITOR [4-(2- REMARK 900 AMINO-4-METHYL- THIAZOL-5-YL)-PYRIMIDIN-2-YL]-(3-NITRO- PHENYL)- REMARK 900 AMINE REMARK 900 RELATED ID: 1KE9 RELATED DB: PDB REMARK 900 CYCLIN-DEPENDENT KINASE 2 (CDK2) COMPLEXED WITH 3-{[4-({ REMARK 900 [AMINO(IMINO)METHYL] AMINOSULFONYL)ANILINO]METHYLENE}-2-OXO-2,3- REMARK 900 DIHYDRO-1H-INDOLE REMARK 900 RELATED ID: 1HCK RELATED DB: PDB REMARK 900 HUMAN CYCLIN-DEPENDENT KINASE 2 REMARK 900 RELATED ID: 2A0C RELATED DB: PDB REMARK 900 HUMAN CDK2 IN COMPLEX WITH OLOMOUCINE II, A NOVEL 2,6,9- REMARK 900 TRISUBSTITUTED PURINE CYCLIN -DEPENDENT KINASE INHIBITOR REMARK 900 RELATED ID: 1JSU RELATED DB: PDB REMARK 900 P27(KIP1)/CYCLIN A/CDK2 COMPLEX REMARK 900 RELATED ID: 1PXN RELATED DB: PDB REMARK 900 HUMAN CYCLIN DEPENDENT KINASE 2 COMPLEXED WITH THEINHIBITOR 4-[4-(4- REMARK 900 METHYL-2- METHYLAMINO-THIAZOL-5-YL)-PYRIMIDIN-2- YLAMINO]-PHENOL REMARK 900 RELATED ID: 2UZE RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN CDK2 COMPLEXED WITH A THIAZOLIDINONE REMARK 900 INHIBITOR REMARK 900 RELATED ID: 2VTM RELATED DB: PDB REMARK 900 IDENTIFICATION OF N-(4-PIPERIDINYL)-4-(2,6 -DICHLOROBENZOYLAMINO)- REMARK 900 1H-PYRAZOLE-3- CARBOXAMIDE (AT7519), A NOVEL CYCLIN DEPENDENT REMARK 900 KINASE INHIBITOR USING FRAGMENT-BASED X- RAY CRYSTALLOGRAPHY AND REMARK 900 STRUCTURE BASED DRUG DESIGN. REMARK 900 RELATED ID: 2V0D RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN CDK2 COMPLEXED WITH A THIAZOLIDINONE REMARK 900 INHIBITOR REMARK 900 RELATED ID: 1OIQ RELATED DB: PDB REMARK 900 IMIDAZOPYRIDINES: A POTENT AND SELECTIVE CLASS OF CYCLIN-DEPENDENT REMARK 900 KINASE INHIBITORS IDENTIFIED THROUGH STRUCTURE-BASED HYBRIDISATION REMARK 900 RELATED ID: 1H1R RELATED DB: PDB REMARK 900 STRUCTURE OF HUMAN THR160-PHOSPHO CDK2/ CYCLIN A COMPLEXED WITH THE REMARK 900 INHIBITOR NU6086 REMARK 900 RELATED ID: 2IW8 RELATED DB: PDB REMARK 900 STRUCTURE OF HUMAN THR160-PHOSPHO CDK2- CYCLIN A F82H-L83V-H84D REMARK 900 MUTANT WITH AN O6-CYCLOHEXYLMETHYLGUANINE INHIBITOR REMARK 900 RELATED ID: 1HCL RELATED DB: PDB REMARK 900 HUMAN CYCLIN-DEPENDENT KINASE 2 REMARK 900 RELATED ID: 1PW2 RELATED DB: PDB REMARK 900 APO STRUCTURE OF HUMAN CYCLIN-DEPENDENT KINASE 2 REMARK 900 RELATED ID: 1GIH RELATED DB: PDB REMARK 900 HUMAN CYCLIN DEPENDENT KINASE 2 COMPLEXED WITH THE CDK4INHIBITOR REMARK 900 RELATED ID: 2VTN RELATED DB: PDB REMARK 900 IDENTIFICATION OF N-(4-PIPERIDINYL)-4-(2,6 -DICHLOROBENZOYLAMINO)- REMARK 900 1H-PYRAZOLE-3- CARBOXAMIDE (AT7519), A NOVEL CYCLIN DEPENDENT REMARK 900 KINASE INHIBITOR USING FRAGMENT-BASED X- RAY CRYSTALLOGRAPHY AND REMARK 900 STRUCTURE BASED DRUG DESIGN. REMARK 900 RELATED ID: 2W06 RELATED DB: PDB REMARK 900 STRUCTURE OF CDK2 IN COMPLEX WITH AN IMIDAZOLYL PYRIMIDINE, REMARK 900 COMPOUND 5C REMARK 900 RELATED ID: 1JST RELATED DB: PDB REMARK 900 PHOSPHORYLATED CYCLIN-DEPENDENT KINASE-2 BOUND TO CYCLIN A REMARK 900 RELATED ID: 1OIU RELATED DB: PDB REMARK 900 STRUCTURE OF HUMAN THR160-PHOSPHO CDK2/ CYCLIN A COMPLEXED WITH A 6- REMARK 900 CYCLOHEXYLMETHYLOXY-2-ANILINO-PURINE INHIBITOR REMARK 900 RELATED ID: 1B38 RELATED DB: PDB REMARK 900 HUMAN CYCLIN-DEPENDENT KINASE 2 REMARK 900 RELATED ID: 1PXM RELATED DB: PDB REMARK 900 HUMAN CYCLIN DEPENDENT KINASE 2 COMPLEXED WITH THEINHIBITOR 3-[4-(2, REMARK 900 4-DIMETHYL- THIAZOL-5-YL)-PYRIMIDIN-2-YLAMINO]-PHENOL REMARK 900 RELATED ID: 1FQ1 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF KINASE ASSOCIATED PHOSPHATASE (KAP) INCOMPLEX REMARK 900 WITH PHOSPHO-CDK2 REMARK 900 RELATED ID: 1VYW RELATED DB: PDB REMARK 900 STRUCTURE OF CDK2/CYCLIN A WITH PNU-292137 REMARK 900 RELATED ID: 1H1P RELATED DB: PDB REMARK 900 STRUCTURE OF HUMAN THR160-PHOSPHO CDK2/ CYCLIN A COMPLEXED WITH THE REMARK 900 INHIBITOR NU2058 REMARK 900 RELATED ID: 2C69 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE HUMAN CDK2 COMPLEXED WITH THE REMARK 900 TRIAZOLOPYRIMIDINE INHIBITOR REMARK 900 RELATED ID: 1URC RELATED DB: PDB REMARK 900 CYCLIN A BINDING GROOVE INHIBITOR H-ARG- ARG-LEU-ASN-(P-F-PHE)-NH2 REMARK 900 RELATED ID: 1PXI RELATED DB: PDB REMARK 900 HUMAN CYCLIN DEPENDENT KINASE 2 COMPLEXED WITH THEINHIBITOR 4-(2,5- REMARK 900 DICHLORO-THIOPHEN- 3-YL)-PYRIMIDIN-2-YLAMINE REMARK 900 RELATED ID: 2C6I RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE HUMAN CDK2 COMPLEXED WITH THE REMARK 900 TRIAZOLOPYRIMIDINE INHIBITOR REMARK 900 RELATED ID: 1YKR RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF CDK2 WITH AN AMINOIMIDAZO PYRIDINEINHIBITOR REMARK 900 RELATED ID: 2W17 RELATED DB: PDB REMARK 900 CDK2 IN COMPLEX WITH THE IMIDAZOLE PYRIMIDINE AMIDE, COMPOUND (S)-8B REMARK 900 RELATED ID: 2C5Y RELATED DB: PDB REMARK 900 DIFFERENTIAL BINDING OF INHIBITORS TO ACTIVE AND INACTIVE CDK2 REMARK 900 PROVIDES INSIGHTS FOR DRUG DESIGN REMARK 900 RELATED ID: 2UZD RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN CDK2 COMPLEXED WITH A THIAZOLIDINONE REMARK 900 INHIBITOR REMARK 900 RELATED ID: 2C6K RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE HUMAN CDK2 COMPLEXED WITH THE REMARK 900 TRIAZOLOPYRIMIDINE INHIBITOR REMARK 900 RELATED ID: 1WCC RELATED DB: PDB REMARK 900 SCREENING FOR FRAGMENT BINDING BY X-RAY CRYSTALLOGRAPHY REMARK 900 RELATED ID: 2J9M RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF CDK2 IN COMPLEX WITH MACROCYCLIC REMARK 900 AMINOPYRIMIDINE REMARK 900 RELATED ID: 1VYZ RELATED DB: PDB REMARK 900 STRUCTURE OF CDK2 COMPLEXED WITH PNU-181227 REMARK 900 RELATED ID: 2VTI RELATED DB: PDB REMARK 900 IDENTIFICATION OF N-(4-PIPERIDINYL)-4-(2,6 -DICHLOROBENZOYLAMINO)- REMARK 900 1H-PYRAZOLE-3- CARBOXAMIDE (AT7519), A NOVEL CYCLIN DEPENDENT REMARK 900 KINASE INHIBITOR USING FRAGMENT-BASED X- RAY CRYSTALLOGRAPHY AND REMARK 900 STRUCTURE BASED DRUG DESIGN. REMARK 900 RELATED ID: 1JVP RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN CDK2 ( UNPHOSPHORYLATED) INCOMPLEX WITH REMARK 900 PKF049-365 REMARK 900 RELATED ID: 1W98 RELATED DB: PDB REMARK 900 THE STRUCTURAL BASIS OF CDK2 ACTIVATION BY CYCLIN E REMARK 900 RELATED ID: 1PKD RELATED DB: PDB REMARK 900 THE CRYSTAL STRUCTURE OF UCN-01 IN COMPLEX WITH PHOSPHO-CDK2/CYCLIN REMARK 900 A REMARK 900 RELATED ID: 1P5E RELATED DB: PDB REMARK 900 THE STRUCURE OF PHOSPHO-CDK2/CYCLIN A IN COMPLEX WITH THEINHIBITOR REMARK 900 4,5,6,7- TETRABROMOBENZOTRIAZOLE (TBS) REMARK 900 RELATED ID: 2VTS RELATED DB: PDB REMARK 900 IDENTIFICATION OF N-(4-PIPERIDINYL)-4-(2,6 -DICHLOROBENZOYLAMINO)- REMARK 900 1H-PYRAZOLE-3- CARBOXAMIDE (AT7519), A NOVEL CYCLIN DEPENDENT REMARK 900 KINASE INHIBITOR USING FRAGMENT-BASED X- RAY CRYSTALLOGRAPHY AND REMARK 900 STRUCTURE BASED DRUG DESIGN. REMARK 900 RELATED ID: 2C5P RELATED DB: PDB REMARK 900 DIFFERENTIAL BINDING OF INHIBITORS TO ACTIVE AND INACTIVE CDK2 REMARK 900 PROVIDES INSIGHTS FOR DRUG DESIGN REMARK 900 RELATED ID: 2UZN RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN CDK2 COMPLEXED WITH A THIAZOLIDINONE REMARK 900 INHIBITOR REMARK 900 RELATED ID: 2B54 RELATED DB: PDB REMARK 900 HUMAN CYCLIN DEPENDENT KINASE 2 (CKD2) COMPLEXED WITH DIN-232305 REMARK 900 RELATED ID: 1PXJ RELATED DB: PDB REMARK 900 HUMAN CYCLIN DEPENDENT KINASE 2 COMPLEXED WITH THEINHIBITOR 4-(2,4- REMARK 900 DIMETHYL-THIAZOL- 5-YL)-PYRIMIDIN-2-YLAMINE REMARK 900 RELATED ID: 1KE6 RELATED DB: PDB REMARK 900 CYCLIN-DEPENDENT KINASE 2 (CDK2) COMPLEXED WITH N-METHYL-{4-[2-(7- REMARK 900 OXO-6,7-DIHYDRO -8H-[1,3]THIAZOLO[5,4-E]INDOL-8- YLIDENE)HYDRAZINO] REMARK 900 PHENYL}METHANESULFONAMIDE REMARK 900 RELATED ID: 2UZL RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN CDK2 COMPLEXED WITH A THIAZOLIDINONE REMARK 900 INHIBITOR REMARK 900 RELATED ID: 2CCI RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF PHOSPHO-CDK2 CYCLIN A IN COMPLEX WITH A REMARK 900 PEPTIDE CONTAINING BOTH THE SUBSTRATE AND RECRUITMENT SITES OF CDC6 REMARK 900 RELATED ID: 2BKZ RELATED DB: PDB REMARK 900 STRUCTURE OF CDK2-CYCLIN A WITH PHA-404611 REMARK 900 RELATED ID: 2G9X RELATED DB: PDB REMARK 900 STRUCTURE OF THR 160 PHOSPHORYLATED CDK2/ CYCLIN A INCOMPLEX WITH REMARK 900 THE INHIBITOR NU6271 REMARK 900 RELATED ID: 1Y91 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN CDK2 COMPLEXED WITH A PYRAZOLO[1,5-A] REMARK 900 PYRIMIDINE INHIBITOR REMARK 900 RELATED ID: 2IW6 RELATED DB: PDB REMARK 900 STRUCTURE OF HUMAN THR160-PHOSPHO CDK2- CYCLIN A COMPLEXED WITH A REMARK 900 BISANILINOPYRIMIDINE INHIBITOR REMARK 900 RELATED ID: 1GIJ RELATED DB: PDB REMARK 900 HUMAN CYCLIN DEPENDENT KINASE 2 COMPLEXED WITH THE CDK4INHIBITOR REMARK 900 RELATED ID: 1R78 RELATED DB: PDB REMARK 900 CDK2 COMPLEX WITH A 4-ALKYNYL OXINDOLE INHIBITOR REMARK 900 RELATED ID: 1H0V RELATED DB: PDB REMARK 900 HUMAN CYCLIN DEPENDENT PROTEIN KINASE 2 IN COMPLEX WITH THE REMARK 900 INHIBITOR 2-AMINO-6-[(R )-PYRROLIDINO-5'-YL]METHOXYPURINE REMARK 900 RELATED ID: 2IW9 RELATED DB: PDB REMARK 900 STRUCTURE OF HUMAN THR160-PHOSPHO CDK2- CYCLIN A COMPLEXED WITH A REMARK 900 BISANILINOPYRIMIDINE INHIBITOR REMARK 900 RELATED ID: 1W8C RELATED DB: PDB REMARK 900 CO-CRYSTAL STRUCTURE OF 6-CYCLOHEXYLMETHOXY- 8-ISOPROPYL-9H-PURIN-2- REMARK 900 YLAMINE AND MONOMERIC CDK2 REMARK 900 RELATED ID: 1BUH RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE HUMAN CDK2 KINASE COMPLEX WITHCELL CYCLE- REMARK 900 REGULATORY PROTEIN CKSHS1 REMARK 900 RELATED ID: 2BPM RELATED DB: PDB REMARK 900 STRUCTURE OF CDK2-CYCLIN A WITH PHA-630529 REMARK 900 RELATED ID: 2BTS RELATED DB: PDB REMARK 900 STRUCTURE OF CDK2 COMPLEXED WITH PNU-230032 REMARK 900 RELATED ID: 1FVV RELATED DB: PDB REMARK 900 THE STRUCTURE OF CDK2/CYCLIN A IN COMPLEX WITH AN OXINDOLEINHIBITOR REMARK 900 RELATED ID: 1OKW RELATED DB: PDB REMARK 900 CYCLIN A BINDING GROOVE INHIBITOR AC-ARG- ARG-LEU-ASN-(M-CL-PHE)-NH2 REMARK 900 RELATED ID: 2VTP RELATED DB: PDB REMARK 900 IDENTIFICATION OF N-(4-PIPERIDINYL)-4-(2,6 -DICHLOROBENZOYLAMINO)- REMARK 900 1H-PYRAZOLE-3- CARBOXAMIDE (AT7519), A NOVEL CYCLIN DEPENDENT REMARK 900 KINASE INHIBITOR USING FRAGMENT-BASED X- RAY CRYSTALLOGRAPHY AND REMARK 900 STRUCTURE BASED DRUG DESIGN. REMARK 900 RELATED ID: 2A4L RELATED DB: PDB REMARK 900 HUMAN CYCLIN-DEPENDENT KINASE 2 IN COMPLEX WITH ROSCOVITINE REMARK 900 RELATED ID: 2C6T RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE HUMAN CDK2 COMPLEXED WITH THE REMARK 900 TRIAZOLOPYRIMIDINE INHIBITOR REMARK 900 RELATED ID: 1FVT RELATED DB: PDB REMARK 900 THE STRUCTURE OF CYCLIN-DEPENDENT KINASE 2 (CDK2) INCOMPLEX WITH AN REMARK 900 OXINDOLE INHIBITOR REMARK 900 RELATED ID: 1QMZ RELATED DB: PDB REMARK 900 PHOSPHORYLATED CDK2-CYCLYIN A-SUBSTRATE PEPTIDE COMPLEX REMARK 900 RELATED ID: 2W1H RELATED DB: PDB REMARK 900 FRAGMENT-BASED DISCOVERY OF THE PYRAZOL-4- YL UREA (AT9283), A REMARK 900 MULTI-TARGETED KINASE INHIBITOR WITH POTENT AURORA KINASE ACTIVITY REMARK 900 RELATED ID: 2VU3 RELATED DB: PDB REMARK 900 IDENTIFICATION OF N-(4-PIPERIDINYL)-4-(2,6 -DICHLOROBENZOYLAMINO)- REMARK 900 1H-PYRAZOLE-3- CARBOXAMIDE (AT7519), A NOVEL CYCLIN DEPENDENT REMARK 900 KINASE INHIBITOR USING FRAGMENT-BASED X- RAY CRYSTALLOGRAPHY AND REMARK 900 STRUCTURE BASED DRUG DESIGN. REMARK 900 RELATED ID: 2B55 RELATED DB: PDB REMARK 900 HUMAN CYCLIN DEPENDENT KINASE 2 (CDK2) COMPLEXED WITHINDENOPYRAXOLE REMARK 900 DIN-101312 REMARK 900 RELATED ID: 1OGU RELATED DB: PDB REMARK 900 STRUCTURE OF HUMAN THR160-PHOSPHO CDK2/ CYCLIN A COMPLEXED WITH A 2- REMARK 900 ARYLAMINO-4- CYCLOHEXYLMETHYL-5-NITROSO-6-AMINOPYRIMIDINE INHIBITOR REMARK 900 RELATED ID: 1PF8 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN CYCLIN-DEPENDENT KINASE 2COMPLEXED WITH REMARK 900 A NUCLEOSIDE INHIBITOR REMARK 900 RELATED ID: 1H1S RELATED DB: PDB REMARK 900 STRUCTURE OF HUMAN THR160-PHOSPHO CDK2/ CYCLIN A COMPLEXED WITH THE REMARK 900 INHIBITOR NU6102 REMARK 900 RELATED ID: 2C5V RELATED DB: PDB REMARK 900 DIFFERENTIAL BINDING OF INHIBITORS TO ACTIVE AND INACTIVE CDK2 REMARK 900 PROVIDES INSIGHTS FOR DRUG DESIGN REMARK 900 RELATED ID: 2JGZ RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF PHOSPHO-CDK2 IN COMPLEX WITH CYCLIN B REMARK 900 RELATED ID: 2BHE RELATED DB: PDB REMARK 900 HUMAN CYCLIN DEPENDENT PROTEIN KINASE 2 IN COMPLEX WITH THE REMARK 900 INHIBITOR 5-BROMO- INDIRUBINE REMARK 900 RELATED ID: 1URW RELATED DB: PDB REMARK 900 CDK2 IN COMPLEX WITH AN IMIDAZO[1,2-B] PYRIDAZINE REMARK 900 RELATED ID: 1OIY RELATED DB: PDB REMARK 900 STRUCTURE OF HUMAN THR160-PHOSPHO CDK2/ CYCLIN A COMPLEXED WITH A 6- REMARK 900 CYCLOHEXYLMETHYLOXY-2-ANILINO-PURINE INHIBITOR REMARK 900 RELATED ID: 2C6L RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE HUMAN CDK2 COMPLEXED WITH THE REMARK 900 TRIAZOLOPYRIMIDINE INHIBITOR REMARK 900 RELATED ID: 1F5Q RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF MURINE GAMMA HERPESVIRUS CYCLIN COMPLEXED TO REMARK 900 HUMAN CYCLIN DEPENDANT KINASE 2 REMARK 900 RELATED ID: 2C6O RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE HUMAN CDK2 COMPLEXED WITH THE REMARK 900 TRIAZOLOPYRIMIDINE INHIBITOR REMARK 900 RELATED ID: 2VTL RELATED DB: PDB REMARK 900 IDENTIFICATION OF N-(4-PIPERIDINYL)-4-(2,6 -DICHLOROBENZOYLAMINO)- REMARK 900 1H-PYRAZOLE-3- CARBOXAMIDE (AT7519), A NOVEL CYCLIN DEPENDENT REMARK 900 KINASE INHIBITOR USING FRAGMENT-BASED X- RAY CRYSTALLOGRAPHY AND REMARK 900 STRUCTURE BASED DRUG DESIGN. REMARK 900 RELATED ID: 1OL1 RELATED DB: PDB REMARK 900 CYCLIN A BINDING GROOVE INHIBITOR H-CIT- CIT-LEU-ILE-(P-F-PHE)-NH2 REMARK 900 RELATED ID: 1H01 RELATED DB: PDB REMARK 900 CDK2 IN COMPLEX WITH A DISUBSTITUTED 2, 4 -BIS ANILINO PYRIMIDINE REMARK 900 CDK4 INHIBITOR REMARK 900 RELATED ID: 2UZB RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN CDK2 COMPLEXED WITH A THIAZOLIDINONE REMARK 900 INHIBITOR REMARK 900 RELATED ID: 1OIR RELATED DB: PDB REMARK 900 IMIDAZOPYRIDINES: A POTENT AND SELECTIVE CLASS OF CYCLIN-DEPENDENT REMARK 900 KINASE INHIBITORS IDENTIFIED THROUGH STRUCTURE-BASED HYBRIDISATION REMARK 900 RELATED ID: 1OI9 RELATED DB: PDB REMARK 900 STRUCTURE OF HUMAN THR160-PHOSPHO CDK2/ CYCLIN A COMPLEXED WITH A 6- REMARK 900 CYCLOHEXYLMETHYLOXY-2-ANILINO-PURINE INHIBITOR REMARK 900 RELATED ID: 2VTJ RELATED DB: PDB REMARK 900 IDENTIFICATION OF N-(4-PIPERIDINYL)-4-(2,6 -DICHLOROBENZOYLAMINO)- REMARK 900 1H-PYRAZOLE-3- CARBOXAMIDE (AT7519), A NOVEL CYCLIN DEPENDENT REMARK 900 KINASE INHIBITOR USING FRAGMENT-BASED X- RAY CRYSTALLOGRAPHY AND REMARK 900 STRUCTURE BASED DRUG DESIGN. REMARK 900 RELATED ID: 2CJM RELATED DB: PDB REMARK 900 MECHANISM OF CDK INHIBITION BY ACTIVE SITE PHOSPHORYLATION: CDK2 REMARK 900 Y15P T160P IN COMPLEX WITH CYCLIN A STRUCTURE REMARK 900 RELATED ID: 2WEV RELATED DB: PDB REMARK 900 TRUNCATION AND OPTIMISATION OF PEPTIDE INHIBITORS OF CDK2, CYCLIN A REMARK 900 THROUGH STRUCTURE GUIDED DESIGN REMARK 900 RELATED ID: 2C5X RELATED DB: PDB REMARK 900 DIFFERENTIAL BINDING OF INHIBITORS TO ACTIVE AND INACTIVE CDK2 REMARK 900 PROVIDES INSIGHTS FOR DRUG DESIGN REMARK 900 RELATED ID: 2C5N RELATED DB: PDB REMARK 900 DIFFERENTIAL BINDING OF INHIBITORS TO ACTIVE AND INACTIVE CDK2 REMARK 900 PROVIDES INSIGHTS FOR DRUG DESIGN REMARK 900 RELATED ID: 2C6M RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE HUMAN CDK2 COMPLEXED WITH THE REMARK 900 TRIAZOLOPYRIMIDINE INHIBITOR REMARK 900 RELATED ID: 1OIT RELATED DB: PDB REMARK 900 IMIDAZOPYRIDINES: A POTENT AND SELECTIVE CLASS OF CYCLIN-DEPENDENT REMARK 900 KINASE INHIBITORS IDENTIFIED THROUGH STRUCTURE-BASED HYBRIDISATION REMARK 900 RELATED ID: 1GY3 RELATED DB: PDB REMARK 900 PCDK2/CYCLIN A IN COMPLEX WITH MGADP, NITRATE AND PEPTIDE SUBSTRATE REMARK 900 RELATED ID: 2V22 RELATED DB: PDB REMARK 900 REPLACE: A STRATEGY FOR ITERATIVE DESIGN OF CYCLIN BINDING GROOVE REMARK 900 INHIBITORS REMARK 900 RELATED ID: 1DI8 RELATED DB: PDB REMARK 900 THE STRUCTURE OF CYCLIN-DEPENDENT KINASE 2 (CDK2) IN COMPLEX WITH 4- REMARK 900 [3- HYDROXYANILINO]-6,7-DIMETHOXYQUINAZOLINE REMARK 900 RELATED ID: 1GII RELATED DB: PDB REMARK 900 HUMAN CYCLIN DEPENDENT KINASE 2 COMPLEXED WITH THE CDK4INHIBITOR REMARK 900 RELATED ID: 2VV9 RELATED DB: PDB REMARK 900 CDK2 IN COMPLEX WITH AN IMIDAZOLE PIPERAZINE REMARK 900 RELATED ID: 1E9H RELATED DB: PDB REMARK 900 THR 160 PHOSPHORYLATED CDK2 - HUMAN CYCLIN A3 COMPLEX WITH THE REMARK 900 INHIBITOR INDIRUBIN-5- SULPHONATE BOUND REMARK 900 RELATED ID: 2VTO RELATED DB: PDB REMARK 900 IDENTIFICATION OF N-(4-PIPERIDINYL)-4-(2,6 -DICHLOROBENZOYLAMINO)- REMARK 900 1H-PYRAZOLE-3- CARBOXAMIDE (AT7519), A NOVEL CYCLIN DEPENDENT REMARK 900 KINASE INHIBITOR USING FRAGMENT-BASED X- RAY CRYSTALLOGRAPHY AND REMARK 900 STRUCTURE BASED DRUG DESIGN. REMARK 900 RELATED ID: 1DM2 RELATED DB: PDB REMARK 900 HUMAN CYCLIN-DEPENDENT KINASE 2 COMPLEXED WITH THE INHIBITOR REMARK 900 HYMENIALDISINE REMARK 900 RELATED ID: 1H24 RELATED DB: PDB REMARK 900 CDK2/CYCLINA IN COMPLEX WITH A 9 RESIDUE RECRUITMENT PEPTIDE FROM REMARK 900 E2F REMARK 900 RELATED ID: 2UZO RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN CDK2 COMPLEXED WITH A THIAZOLIDINONE REMARK 900 INHIBITOR REMARK 900 RELATED ID: 2EXM RELATED DB: PDB REMARK 900 HUMAN CDK2 IN COMPLEX WITH ISOPENTENYLADENINE REMARK 900 RELATED ID: 1H00 RELATED DB: PDB REMARK 900 CDK2 IN COMPLEX WITH A DISUBSTITUTED 4, 6 -BIS ANILINO PYRIMIDINE REMARK 900 CDK4 INHIBITOR REMARK 900 RELATED ID: 2CLX RELATED DB: PDB REMARK 900 4-ARYLAZO-3,5-DIAMINO-1H-PYRAZOLE CDK INHIBITORS: SAR STUDY, REMARK 900 CRYSTAL STRUCTURE IN COMPLEX WITH CDK2, SELECTIVITY, AND CELLULAR REMARK 900 EFFECTS REMARK 900 RELATED ID: 1PXP RELATED DB: PDB REMARK 900 HUMAN CYCLIN DEPENDENT KINASE 2 COMPLEXED WITH THEINHIBITOR N-[4-(2, REMARK 900 4-DIMETHYL- THIAZOL-5-YL)-PYRIMIDIN-2-YL]-N',N'- DIMETHYL-BENZENE-1, REMARK 900 4-DIAMINE REMARK 900 RELATED ID: 2CCH RELATED DB: PDB REMARK 900 THE CRYSTAL STRUCTURE OF CDK2 CYCLIN A IN COMPLEX WITH A SUBSTRATE REMARK 900 PEPTIDE DERIVED FROM CDC MODIFIED WITH A GAMMA-LINKED ATP ANALOGUE REMARK 900 RELATED ID: 1B39 RELATED DB: PDB REMARK 900 HUMAN CYCLIN-DEPENDENT KINASE 2 PHOSPHORYLATED ON THR 160 REMARK 900 RELATED ID: 2BTR RELATED DB: PDB REMARK 900 STRUCTURE OF CDK2 COMPLEXED WITH PNU-198873 REMARK 900 RELATED ID: 1AQ1 RELATED DB: PDB REMARK 900 HUMAN CYCLIN DEPENDENT KINASE 2 COMPLEXED WITH THE INHIBITOR REMARK 900 STAUROSPORINE REMARK 900 RELATED ID: 1H0W RELATED DB: PDB REMARK 900 HUMAN CYCLIN DEPENDENT PROTEIN KINASE 2 IN COMPLEX WITH THE REMARK 900 INHIBITOR 2-AMINO-6-[ CYCLOHEX-3-ENYL]METHOXYPURINE REMARK 900 RELATED ID: 1G5S RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN CYCLIN DEPENDENT KINASE 2 (CDK2)IN REMARK 900 COMPLEX WITH THE INHIBITOR H717 REMARK 900 RELATED ID: 1CKP RELATED DB: PDB REMARK 900 HUMAN CYCLIN DEPENDENT KINASE 2 COMPLEXED WITH THE INHIBITOR REMARK 900 PURVALANOL B REMARK 900 RELATED ID: 1KE8 RELATED DB: PDB REMARK 900 CYCLIN-DEPENDENT KINASE 2 (CDK2) COMPLEXED WITH 4-{[(2-OXO-1,2- REMARK 900 DIHYDRO-3H-INDOL-3 -YLIDENE)METHYL]AMINO}-N-(1,3-THIAZOL-2- YL) REMARK 900 BENZENESULFONAMIDE REMARK 900 RELATED ID: 1H28 RELATED DB: PDB REMARK 900 CDK2/CYCLINA IN COMPLEX WITH AN 11-RESIDUE RECRUITMENT PEPTIDE FROM REMARK 900 P107 REMARK 900 RELATED ID: 1PXL RELATED DB: PDB REMARK 900 HUMAN CYCLIN DEPENDENT KINASE 2 COMPLEXED WITH THEINHIBITOR [4-(2,4- REMARK 900 DIMETHYL-THIAZOL- 5-YL)-PYRIMIDIN-2-YL]-(4-TRIFLUOROMETHYL- PHENYL)- REMARK 900 AMINE REMARK 900 RELATED ID: 2VTR RELATED DB: PDB REMARK 900 IDENTIFICATION OF N-(4-PIPERIDINYL)-4-(2,6 -DICHLOROBENZOYLAMINO)- REMARK 900 1H-PYRAZOLE-3- CARBOXAMIDE (AT7519), A NOVEL CYCLIN DEPENDENT REMARK 900 KINASE INHIBITOR USING FRAGMENT-BASED X- RAY CRYSTALLOGRAPHY AND REMARK 900 STRUCTURE BASED DRUG DESIGN. REMARK 900 RELATED ID: 1H26 RELATED DB: PDB REMARK 900 CDK2/CYCLINA IN COMPLEX WITH AN 11-RESIDUE RECRUITMENT PEPTIDE FROM REMARK 900 P53 REMARK 900 RELATED ID: 1E1X RELATED DB: PDB REMARK 900 HUMAN CYCLIN DEPENDENT KINASE 2 COMPLEXED WITH THE INHIBITOR NU6027 REMARK 900 RELATED ID: 1H07 RELATED DB: PDB REMARK 900 CDK2 IN COMPLEX WITH A DISUBSTITUTED 4, 6 -BIS ANILINO PYRIMIDINE REMARK 900 CDK4 INHIBITOR REMARK 900 RELATED ID: 1Y8Y RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN CDK2 COMPLEXED WITH A PYRAZOLO[1,5-A] REMARK 900 PYRIMIDINE INHIBITOR REMARK 999 REMARK 999 SEQUENCE REMARK 999 FRACTION 172-432 CRYSTALLISED IN COMPLEX WITH CDK2 DBREF 2WFY A 1 298 UNP P24941 CDK2_HUMAN 1 298 DBREF 2WFY B 173 432 UNP P20248 CCNA2_HUMAN 173 432 DBREF 2WFY C 1 298 UNP P24941 CDK2_HUMAN 1 298 DBREF 2WFY D 173 432 UNP P20248 CCNA2_HUMAN 173 432 DBREF 2WFY E 1 6 PDB 2WFY 2WFY 1 6 DBREF 2WFY F 1 6 PDB 2WFY 2WFY 1 6 SEQRES 1 A 298 MET GLU ASN PHE GLN LYS VAL GLU LYS ILE GLY GLU GLY SEQRES 2 A 298 THR TYR GLY VAL VAL TYR LYS ALA ARG ASN LYS LEU THR SEQRES 3 A 298 GLY GLU VAL VAL ALA LEU LYS LYS ILE ARG LEU ASP THR SEQRES 4 A 298 GLU THR GLU GLY VAL PRO SER THR ALA ILE ARG GLU ILE SEQRES 5 A 298 SER LEU LEU LYS GLU LEU ASN HIS PRO ASN ILE VAL LYS SEQRES 6 A 298 LEU LEU ASP VAL ILE HIS THR GLU ASN LYS LEU TYR LEU SEQRES 7 A 298 VAL PHE GLU PHE LEU HIS GLN ASP LEU LYS LYS PHE MET SEQRES 8 A 298 ASP ALA SER ALA LEU THR GLY ILE PRO LEU PRO LEU ILE SEQRES 9 A 298 LYS SER TYR LEU PHE GLN LEU LEU GLN GLY LEU ALA PHE SEQRES 10 A 298 CYS HIS SER HIS ARG VAL LEU HIS ARG ASP LEU LYS PRO SEQRES 11 A 298 GLN ASN LEU LEU ILE ASN THR GLU GLY ALA ILE LYS LEU SEQRES 12 A 298 ALA ASP PHE GLY LEU ALA ARG ALA PHE GLY VAL PRO VAL SEQRES 13 A 298 ARG THR TYR THR HIS GLU VAL VAL THR LEU TRP TYR ARG SEQRES 14 A 298 ALA PRO GLU ILE LEU LEU GLY CYS LYS TYR TYR SER THR SEQRES 15 A 298 ALA VAL ASP ILE TRP SER LEU GLY CYS ILE PHE ALA GLU SEQRES 16 A 298 MET VAL THR ARG ARG ALA LEU PHE PRO GLY ASP SER GLU SEQRES 17 A 298 ILE ASP GLN LEU PHE ARG ILE PHE ARG THR LEU GLY THR SEQRES 18 A 298 PRO ASP GLU VAL VAL TRP PRO GLY VAL THR SER MET PRO SEQRES 19 A 298 ASP TYR LYS PRO SER PHE PRO LYS TRP ALA ARG GLN ASP SEQRES 20 A 298 PHE SER LYS VAL VAL PRO PRO LEU ASP GLU ASP GLY ARG SEQRES 21 A 298 SER LEU LEU SER GLN MET LEU HIS TYR ASP PRO ASN LYS SEQRES 22 A 298 ARG ILE SER ALA LYS ALA ALA LEU ALA HIS PRO PHE PHE SEQRES 23 A 298 GLN ASP VAL THR LYS PRO VAL PRO HIS LEU ARG LEU SEQRES 1 B 260 ASN GLU VAL PRO ASP TYR HIS GLU ASP ILE HIS THR TYR SEQRES 2 B 260 LEU ARG GLU MET GLU VAL LYS CYS LYS PRO LYS VAL GLY SEQRES 3 B 260 TYR MET LYS LYS GLN PRO ASP ILE THR ASN SER MET ARG SEQRES 4 B 260 ALA ILE LEU VAL ASP TRP LEU VAL GLU VAL GLY GLU GLU SEQRES 5 B 260 TYR LYS LEU GLN ASN GLU THR LEU HIS LEU ALA VAL ASN SEQRES 6 B 260 TYR ILE ASP ARG PHE LEU SER SER MET SER VAL LEU ARG SEQRES 7 B 260 GLY LYS LEU GLN LEU VAL GLY THR ALA ALA MET LEU LEU SEQRES 8 B 260 ALA SER LYS PHE GLU GLU ILE TYR PRO PRO GLU VAL ALA SEQRES 9 B 260 GLU PHE VAL TYR ILE THR ASP ASP THR TYR THR LYS LYS SEQRES 10 B 260 GLN VAL LEU ARG MET GLU HIS LEU VAL LEU LYS VAL LEU SEQRES 11 B 260 THR PHE ASP LEU ALA ALA PRO THR VAL ASN GLN PHE LEU SEQRES 12 B 260 THR GLN TYR PHE LEU HIS GLN GLN PRO ALA ASN CYS LYS SEQRES 13 B 260 VAL GLU SER LEU ALA MET PHE LEU GLY GLU LEU SER LEU SEQRES 14 B 260 ILE ASP ALA ASP PRO TYR LEU LYS TYR LEU PRO SER VAL SEQRES 15 B 260 ILE ALA GLY ALA ALA PHE HIS LEU ALA LEU TYR THR VAL SEQRES 16 B 260 THR GLY GLN SER TRP PRO GLU SER LEU ILE ARG LYS THR SEQRES 17 B 260 GLY TYR THR LEU GLU SER LEU LYS PRO CYS LEU MET ASP SEQRES 18 B 260 LEU HIS GLN THR TYR LEU LYS ALA PRO GLN HIS ALA GLN SEQRES 19 B 260 GLN SER ILE ARG GLU LYS TYR LYS ASN SER LYS TYR HIS SEQRES 20 B 260 GLY VAL SER LEU LEU ASN PRO PRO GLU THR LEU ASN LEU SEQRES 1 C 298 MET GLU ASN PHE GLN LYS VAL GLU LYS ILE GLY GLU GLY SEQRES 2 C 298 THR TYR GLY VAL VAL TYR LYS ALA ARG ASN LYS LEU THR SEQRES 3 C 298 GLY GLU VAL VAL ALA LEU LYS LYS ILE ARG LEU ASP THR SEQRES 4 C 298 GLU THR GLU GLY VAL PRO SER THR ALA ILE ARG GLU ILE SEQRES 5 C 298 SER LEU LEU LYS GLU LEU ASN HIS PRO ASN ILE VAL LYS SEQRES 6 C 298 LEU LEU ASP VAL ILE HIS THR GLU ASN LYS LEU TYR LEU SEQRES 7 C 298 VAL PHE GLU PHE LEU HIS GLN ASP LEU LYS LYS PHE MET SEQRES 8 C 298 ASP ALA SER ALA LEU THR GLY ILE PRO LEU PRO LEU ILE SEQRES 9 C 298 LYS SER TYR LEU PHE GLN LEU LEU GLN GLY LEU ALA PHE SEQRES 10 C 298 CYS HIS SER HIS ARG VAL LEU HIS ARG ASP LEU LYS PRO SEQRES 11 C 298 GLN ASN LEU LEU ILE ASN THR GLU GLY ALA ILE LYS LEU SEQRES 12 C 298 ALA ASP PHE GLY LEU ALA ARG ALA PHE GLY VAL PRO VAL SEQRES 13 C 298 ARG THR TYR THR HIS GLU VAL VAL THR LEU TRP TYR ARG SEQRES 14 C 298 ALA PRO GLU ILE LEU LEU GLY CYS LYS TYR TYR SER THR SEQRES 15 C 298 ALA VAL ASP ILE TRP SER LEU GLY CYS ILE PHE ALA GLU SEQRES 16 C 298 MET VAL THR ARG ARG ALA LEU PHE PRO GLY ASP SER GLU SEQRES 17 C 298 ILE ASP GLN LEU PHE ARG ILE PHE ARG THR LEU GLY THR SEQRES 18 C 298 PRO ASP GLU VAL VAL TRP PRO GLY VAL THR SER MET PRO SEQRES 19 C 298 ASP TYR LYS PRO SER PHE PRO LYS TRP ALA ARG GLN ASP SEQRES 20 C 298 PHE SER LYS VAL VAL PRO PRO LEU ASP GLU ASP GLY ARG SEQRES 21 C 298 SER LEU LEU SER GLN MET LEU HIS TYR ASP PRO ASN LYS SEQRES 22 C 298 ARG ILE SER ALA LYS ALA ALA LEU ALA HIS PRO PHE PHE SEQRES 23 C 298 GLN ASP VAL THR LYS PRO VAL PRO HIS LEU ARG LEU SEQRES 1 D 260 ASN GLU VAL PRO ASP TYR HIS GLU ASP ILE HIS THR TYR SEQRES 2 D 260 LEU ARG GLU MET GLU VAL LYS CYS LYS PRO LYS VAL GLY SEQRES 3 D 260 TYR MET LYS LYS GLN PRO ASP ILE THR ASN SER MET ARG SEQRES 4 D 260 ALA ILE LEU VAL ASP TRP LEU VAL GLU VAL GLY GLU GLU SEQRES 5 D 260 TYR LYS LEU GLN ASN GLU THR LEU HIS LEU ALA VAL ASN SEQRES 6 D 260 TYR ILE ASP ARG PHE LEU SER SER MET SER VAL LEU ARG SEQRES 7 D 260 GLY LYS LEU GLN LEU VAL GLY THR ALA ALA MET LEU LEU SEQRES 8 D 260 ALA SER LYS PHE GLU GLU ILE TYR PRO PRO GLU VAL ALA SEQRES 9 D 260 GLU PHE VAL TYR ILE THR ASP ASP THR TYR THR LYS LYS SEQRES 10 D 260 GLN VAL LEU ARG MET GLU HIS LEU VAL LEU LYS VAL LEU SEQRES 11 D 260 THR PHE ASP LEU ALA ALA PRO THR VAL ASN GLN PHE LEU SEQRES 12 D 260 THR GLN TYR PHE LEU HIS GLN GLN PRO ALA ASN CYS LYS SEQRES 13 D 260 VAL GLU SER LEU ALA MET PHE LEU GLY GLU LEU SER LEU SEQRES 14 D 260 ILE ASP ALA ASP PRO TYR LEU LYS TYR LEU PRO SER VAL SEQRES 15 D 260 ILE ALA GLY ALA ALA PHE HIS LEU ALA LEU TYR THR VAL SEQRES 16 D 260 THR GLY GLN SER TRP PRO GLU SER LEU ILE ARG LYS THR SEQRES 17 D 260 GLY TYR THR LEU GLU SER LEU LYS PRO CYS LEU MET ASP SEQRES 18 D 260 LEU HIS GLN THR TYR LEU LYS ALA PRO GLN HIS ALA GLN SEQRES 19 D 260 GLN SER ILE ARG GLU LYS TYR LYS ASN SER LYS TYR HIS SEQRES 20 D 260 GLY VAL SER LEU LEU ASN PRO PRO GLU THR LEU ASN LEU SEQRES 1 E 6 ACE ARG ARG B3L PHE NH2 SEQRES 1 F 6 ACE ARG ARG B3L PHE NH2 HET ACE E 1 3 HET B3L E 4 9 HET NH2 E 6 1 HET ACE F 1 3 HET B3L F 4 9 HET NH2 F 6 1 HETNAM ACE ACETYL GROUP HETNAM B3L (3S)-3-AMINO-5-METHYLHEXANOIC ACID HETNAM NH2 AMINO GROUP HETSYN B3L (S)-BETA-3-HOMOLEUCINE FORMUL 5 ACE 2(C2 H4 O) FORMUL 5 B3L 2(C7 H15 N O2) FORMUL 5 NH2 2(H2 N) FORMUL 7 HOH *443(H2 O) HELIX 1 1 PRO A 45 LEU A 58 1 14 HELIX 2 2 LEU A 87 ALA A 95 1 9 HELIX 3 3 PRO A 100 SER A 120 1 21 HELIX 4 4 LYS A 129 GLN A 131 5 3 HELIX 5 5 THR A 165 ARG A 169 5 5 HELIX 6 6 ALA A 170 LEU A 175 1 6 HELIX 7 7 THR A 182 ARG A 199 1 18 HELIX 8 8 SER A 207 GLY A 220 1 14 HELIX 9 9 GLY A 229 MET A 233 5 5 HELIX 10 10 ASP A 247 VAL A 252 1 6 HELIX 11 11 ASP A 256 LEU A 267 1 12 HELIX 12 12 SER A 276 LEU A 281 1 6 HELIX 13 13 ALA A 282 GLN A 287 5 6 HELIX 14 14 TYR B 178 CYS B 193 1 16 HELIX 15 15 GLY B 198 GLN B 203 5 6 HELIX 16 16 THR B 207 TYR B 225 1 19 HELIX 17 17 GLN B 228 SER B 244 1 17 HELIX 18 18 LEU B 249 GLU B 269 1 21 HELIX 19 19 GLU B 274 ILE B 281 1 8 HELIX 20 20 THR B 287 LEU B 302 1 16 HELIX 21 21 THR B 310 LEU B 320 1 11 HELIX 22 22 ASN B 326 ASP B 343 1 18 HELIX 23 23 ASP B 343 LEU B 348 1 6 HELIX 24 24 LEU B 351 GLY B 369 1 19 HELIX 25 25 PRO B 373 GLY B 381 1 9 HELIX 26 26 LEU B 387 ALA B 401 1 15 HELIX 27 27 PRO B 402 HIS B 404 5 3 HELIX 28 28 GLN B 407 TYR B 413 1 7 HELIX 29 29 LYS B 414 HIS B 419 5 6 HELIX 30 30 GLY B 420 LEU B 424 5 5 HELIX 31 31 PRO C 45 LEU C 58 1 14 HELIX 32 32 LEU C 87 ALA C 93 1 7 HELIX 33 33 PRO C 100 SER C 120 1 21 HELIX 34 34 LYS C 129 GLN C 131 5 3 HELIX 35 35 THR C 165 ARG C 169 5 5 HELIX 36 36 ALA C 170 LEU C 175 1 6 HELIX 37 37 THR C 182 ARG C 199 1 18 HELIX 38 38 SER C 207 GLY C 220 1 14 HELIX 39 39 GLY C 229 MET C 233 5 5 HELIX 40 40 ASP C 247 VAL C 252 1 6 HELIX 41 41 ASP C 256 LEU C 267 1 12 HELIX 42 42 SER C 276 LEU C 281 1 6 HELIX 43 43 ALA C 282 GLN C 287 5 6 HELIX 44 44 TYR D 178 CYS D 193 1 16 HELIX 45 45 GLY D 198 GLN D 203 5 6 HELIX 46 46 THR D 207 LYS D 226 1 20 HELIX 47 47 GLN D 228 LEU D 243 1 16 HELIX 48 48 LEU D 249 GLY D 251 5 3 HELIX 49 49 LYS D 252 GLU D 269 1 18 HELIX 50 50 GLU D 274 ILE D 281 1 8 HELIX 51 51 THR D 287 THR D 303 1 17 HELIX 52 52 THR D 310 LEU D 320 1 11 HELIX 53 53 ASN D 326 ASP D 343 1 18 HELIX 54 54 ASP D 343 LEU D 348 1 6 HELIX 55 55 LEU D 351 THR D 368 1 18 HELIX 56 56 PRO D 373 GLY D 381 1 9 HELIX 57 57 THR D 383 ALA D 401 1 19 HELIX 58 58 PRO D 402 HIS D 404 5 3 HELIX 59 59 GLN D 407 TYR D 413 1 7 HELIX 60 60 LYS D 414 HIS D 419 5 6 HELIX 61 61 GLY D 420 LEU D 424 5 5 SHEET 1 AA 5 PHE A 4 GLY A 13 0 SHEET 2 AA 5 GLY A 16 ASN A 23 -1 O GLY A 16 N GLY A 13 SHEET 3 AA 5 VAL A 29 ARG A 36 -1 O VAL A 30 N ALA A 21 SHEET 4 AA 5 LYS A 75 GLU A 81 -1 O LEU A 76 N ILE A 35 SHEET 5 AA 5 LEU A 66 HIS A 71 -1 N LEU A 67 O VAL A 79 SHEET 1 AB 3 GLN A 85 ASP A 86 0 SHEET 2 AB 3 LEU A 133 ILE A 135 -1 O ILE A 135 N GLN A 85 SHEET 3 AB 3 ILE A 141 LEU A 143 -1 O LYS A 142 N LEU A 134 SHEET 1 AC 2 VAL A 123 LEU A 124 0 SHEET 2 AC 2 ARG A 150 ALA A 151 -1 O ARG A 150 N LEU A 124 SHEET 1 CA 5 PHE C 4 GLY C 13 0 SHEET 2 CA 5 GLY C 16 ASN C 23 -1 O GLY C 16 N GLY C 13 SHEET 3 CA 5 VAL C 29 ARG C 36 -1 O VAL C 30 N ALA C 21 SHEET 4 CA 5 LYS C 75 GLU C 81 -1 O LEU C 76 N ILE C 35 SHEET 5 CA 5 LEU C 66 HIS C 71 -1 N LEU C 67 O VAL C 79 SHEET 1 CB 3 GLN C 85 ASP C 86 0 SHEET 2 CB 3 LEU C 133 ILE C 135 -1 O ILE C 135 N GLN C 85 SHEET 3 CB 3 ILE C 141 LEU C 143 -1 O LYS C 142 N LEU C 134 SHEET 1 CC 2 VAL C 123 LEU C 124 0 SHEET 2 CC 2 ARG C 150 ALA C 151 -1 O ARG C 150 N LEU C 124 LINK C ACE E 1 N ARG E 2 1555 1555 1.35 LINK C ARG E 3 N B3L E 4 1555 1555 1.34 LINK C B3L E 4 N PHE E 5 1555 1555 1.36 LINK C PHE E 5 N NH2 E 6 1555 1555 1.35 LINK C ACE F 1 N ARG F 2 1555 1555 1.37 LINK C ARG F 3 N B3L F 4 1555 1555 1.33 LINK C B3L F 4 N PHE F 5 1555 1555 1.36 LINK C PHE F 5 N NH2 F 6 1555 1555 1.33 CISPEP 1 GLN B 323 PRO B 324 0 -2.36 CISPEP 2 ASP B 345 PRO B 346 0 8.90 CISPEP 3 GLN D 323 PRO D 324 0 -3.16 CISPEP 4 ASP D 345 PRO D 346 0 6.11 SITE 1 AC1 17 GLU A 12 GLY A 13 VAL A 163 HOH A2004 SITE 2 AC1 17 HOH A2010 HOH A2013 MET B 210 TRP B 217 SITE 3 AC1 17 GLU B 220 ARG B 250 GLN B 254 ILE B 281 SITE 4 AC1 17 THR B 282 ASP B 283 HOH B2025 HOH E2001 SITE 5 AC1 17 HOH E2002 SITE 1 AC2 13 SER C 249 MET D 210 GLU D 220 ARG D 250 SITE 2 AC2 13 LEU D 253 GLN D 254 ILE D 281 THR D 282 SITE 3 AC2 13 THR D 285 HOH D2041 HOH F2001 HOH F2003 SITE 4 AC2 13 HOH F2004 CRYST1 74.621 115.813 157.911 90.00 90.00 90.00 P 21 21 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.013401 0.000000 0.000000 0.00000 SCALE2 0.000000 0.008635 0.000000 0.00000 SCALE3 0.000000 0.000000 0.006333 0.00000 TER 2385 LEU A 296 TER 4467 LEU B 432 TER 6847 ARG C 297 TER 8947 LEU D 432 HETATM 8948 C ACE E 1 35.788 20.424 -2.472 0.80 69.93 C HETATM 8949 O ACE E 1 36.249 20.438 -3.607 0.80 71.74 O HETATM 8950 CH3 ACE E 1 34.556 19.571 -2.254 0.80 68.90 C HETATM 8973 O B3L E 4 44.666 25.816 0.477 0.80 59.58 O HETATM 8974 C B3L E 4 44.305 26.342 1.517 0.80 57.30 C HETATM 8975 CB B3L E 4 43.000 26.217 1.904 0.80 50.38 C HETATM 8976 CA B3L E 4 41.893 25.613 1.032 0.80 50.03 C HETATM 8977 N B3L E 4 40.800 24.963 1.766 0.80 51.65 N HETATM 8978 CG B3L E 4 41.351 26.672 0.080 0.80 51.58 C HETATM 8979 CD B3L E 4 40.090 26.554 -0.756 0.80 49.49 C HETATM 8980 CE2 B3L E 4 39.794 27.857 -1.503 0.80 49.21 C HETATM 8981 CE1 B3L E 4 40.223 25.461 -1.806 0.80 51.67 C HETATM 8993 N NH2 E 6 47.560 28.424 3.434 0.80 66.57 N TER 8994 NH2 E 6 HETATM 8995 C ACE F 1 12.833 79.763 29.094 0.80 58.98 C HETATM 8996 O ACE F 1 12.347 79.520 30.198 0.80 52.96 O HETATM 8997 CH3 ACE F 1 14.334 80.145 29.101 0.80 54.77 C HETATM 9020 O B3L F 4 6.160 78.536 20.618 0.80 56.75 O HETATM 9021 C B3L F 4 6.185 77.338 20.409 0.80 59.65 C HETATM 9022 CB B3L F 4 6.948 76.535 21.215 0.80 52.84 C HETATM 9023 CA B3L F 4 8.201 77.080 21.906 0.80 55.17 C HETATM 9024 N B3L F 4 8.630 76.390 23.126 0.80 53.50 N HETATM 9025 CG B3L F 4 9.381 77.260 20.955 0.80 53.79 C HETATM 9026 CD B3L F 4 10.778 77.602 21.450 0.80 49.01 C HETATM 9027 CE2 B3L F 4 11.836 77.282 20.410 0.80 45.10 C HETATM 9028 CE1 B3L F 4 10.929 79.083 21.745 0.80 47.34 C HETATM 9040 N NH2 F 6 3.580 76.356 17.263 0.80 67.57 N TER 9041 NH2 F 6 HETATM 9042 O HOH A2001 11.541 48.327 20.213 1.00 61.87 O HETATM 9043 O HOH A2002 16.237 47.786 20.259 1.00 80.61 O HETATM 9044 O HOH A2003 16.154 55.279 15.617 1.00 38.88 O HETATM 9045 O HOH A2004 11.802 30.169 0.626 1.00 58.09 O HETATM 9046 O HOH A2005 6.591 49.153 19.893 1.00 52.45 O HETATM 9047 O HOH A2006 14.328 56.352 10.589 1.00 47.95 O HETATM 9048 O HOH A2007 9.902 60.502 3.446 1.00 47.55 O HETATM 9049 O HOH A2008 0.824 61.498 12.568 1.00 65.50 O HETATM 9050 O HOH A2009 2.316 65.208 11.155 1.00 43.98 O HETATM 9051 O HOH A2010 3.446 37.081 6.838 1.00 64.31 O HETATM 9052 O HOH A2011 3.429 38.788 -0.537 1.00 56.11 O HETATM 9053 O HOH A2012 8.111 40.255 -2.922 1.00 58.34 O HETATM 9054 O HOH A2013 5.174 36.525 1.163 1.00 60.28 O HETATM 9055 O HOH A2014 10.000 37.420 7.234 1.00 65.53 O HETATM 9056 O HOH A2015 14.217 30.724 1.974 1.00 61.09 O HETATM 9057 O HOH A2016 1.011 40.639 14.292 1.00 66.86 O HETATM 9058 O HOH A2017 5.742 40.166 13.867 1.00 64.15 O HETATM 9059 O HOH A2018 6.692 59.380 23.257 1.00 48.35 O HETATM 9060 O HOH A2019 15.387 56.700 13.444 1.00 43.55 O HETATM 9061 O HOH A2020 6.035 60.211 17.822 1.00 92.45 O HETATM 9062 O HOH A2021 3.615 61.270 16.056 1.00 40.67 O HETATM 9063 O HOH A2022 3.676 62.513 11.426 1.00 53.57 O HETATM 9064 O HOH A2023 12.197 61.682 11.427 1.00 34.53 O HETATM 9065 O HOH A2024 8.591 60.626 5.923 1.00 45.38 O HETATM 9066 O HOH A2025 13.538 58.659 8.884 1.00 56.11 O HETATM 9067 O HOH A2026 12.479 61.272 7.839 1.00 50.86 O HETATM 9068 O HOH A2027 11.894 57.828 11.382 1.00 52.10 O HETATM 9069 O HOH A2028 4.940 61.648 9.560 1.00 42.74 O HETATM 9070 O HOH A2029 6.676 58.651 6.734 1.00 47.45 O HETATM 9071 O HOH A2030 6.035 50.093 2.051 1.00 60.14 O HETATM 9072 O HOH A2031 16.690 32.701 14.485 1.00 72.64 O HETATM 9073 O HOH A2032 15.732 32.032 7.553 1.00 87.60 O HETATM 9074 O HOH A2033 19.990 23.998 10.094 1.00 75.19 O HETATM 9075 O HOH A2034 2.168 65.427 -9.028 1.00 61.69 O HETATM 9076 O HOH A2035 12.077 29.004 6.339 1.00 68.78 O HETATM 9077 O HOH A2036 20.137 25.133 3.448 1.00 69.96 O HETATM 9078 O HOH A2037 15.643 33.104 3.648 1.00 71.92 O HETATM 9079 O HOH A2038 14.007 54.984 -1.621 1.00 53.82 O HETATM 9080 O HOH A2039 13.797 62.677 -5.423 1.00 59.58 O HETATM 9081 O HOH A2040 18.007 58.938 -6.997 1.00 57.63 O HETATM 9082 O HOH A2041 14.503 62.794 -8.298 1.00 54.00 O HETATM 9083 O HOH A2042 18.930 31.960 -28.222 1.00 55.76 O HETATM 9084 O HOH A2043 9.125 59.246 -2.539 1.00 45.39 O HETATM 9085 O HOH A2044 21.081 48.687 12.608 1.00 62.68 O HETATM 9086 O HOH A2045 20.319 42.130 18.657 1.00 64.76 O HETATM 9087 O HOH A2046 21.051 33.350 16.136 1.00 69.93 O HETATM 9088 O HOH A2047 9.098 41.302 19.401 1.00 64.53 O HETATM 9089 O HOH A2048 -16.722 39.075 -24.570 1.00 68.16 O HETATM 9090 O HOH A2049 2.755 52.699 4.107 1.00 41.21 O HETATM 9091 O HOH A2050 -3.025 51.909 6.556 1.00 49.43 O HETATM 9092 O HOH A2051 -4.100 49.351 2.209 1.00 62.60 O HETATM 9093 O HOH A2052 14.238 39.243 -30.652 1.00 48.34 O HETATM 9094 O HOH A2053 -16.737 59.619 -6.425 1.00 66.68 O HETATM 9095 O HOH A2054 -10.900 70.099 -22.018 1.00 71.06 O HETATM 9096 O HOH A2055 -3.421 63.560 -8.146 1.00 38.67 O HETATM 9097 O HOH A2056 -3.306 59.907 -4.169 1.00 42.35 O HETATM 9098 O HOH A2057 3.168 63.688 -6.513 1.00 53.21 O HETATM 9099 O HOH A2058 3.460 64.417 -11.323 1.00 51.56 O HETATM 9100 O HOH A2059 7.161 67.204 -14.977 1.00 61.69 O HETATM 9101 O HOH A2060 13.951 58.886 -16.566 1.00 54.80 O HETATM 9102 O HOH A2061 24.362 47.246 -12.316 1.00 56.93 O HETATM 9103 O HOH A2062 3.523 40.959 -5.139 1.00 56.30 O HETATM 9104 O HOH A2063 -4.255 43.929 -7.354 1.00 72.08 O HETATM 9105 O HOH A2064 2.499 64.671 -1.542 1.00 48.48 O HETATM 9106 O HOH A2065 2.109 60.934 2.444 1.00 52.84 O HETATM 9107 O HOH A2066 -1.985 61.798 3.520 1.00 50.76 O HETATM 9108 O HOH A2067 5.240 62.857 -1.008 1.00 48.40 O HETATM 9109 O HOH A2068 8.895 43.790 -7.280 1.00 39.89 O HETATM 9110 O HOH A2069 12.924 38.101 -5.369 1.00 41.55 O HETATM 9111 O HOH A2070 12.106 38.690 -10.746 1.00 35.17 O HETATM 9112 O HOH A2071 18.887 41.766 -9.534 1.00 49.55 O HETATM 9113 O HOH A2072 14.057 36.472 -10.463 1.00 54.42 O HETATM 9114 O HOH A2073 23.039 44.706 -13.585 1.00 62.91 O HETATM 9115 O HOH A2074 21.700 37.329 -19.098 1.00 38.99 O HETATM 9116 O HOH A2075 20.373 28.194 -21.811 1.00 52.93 O HETATM 9117 O HOH A2076 16.601 32.009 -20.023 1.00 61.65 O HETATM 9118 O HOH A2077 13.354 29.012 -13.817 1.00 55.82 O HETATM 9119 O HOH A2078 10.854 28.548 -12.884 1.00 52.50 O HETATM 9120 O HOH A2079 4.212 31.040 -6.236 1.00 73.33 O HETATM 9121 O HOH A2080 0.949 36.589 -6.929 1.00 68.04 O HETATM 9122 O HOH A2081 -6.046 36.269 -10.426 1.00 59.84 O HETATM 9123 O HOH A2082 -2.121 40.439 -19.202 1.00 33.02 O HETATM 9124 O HOH A2083 3.787 41.845 -17.757 1.00 60.99 O HETATM 9125 O HOH A2084 21.942 30.648 -22.632 1.00 62.39 O HETATM 9126 O HOH A2085 13.334 34.797 -26.324 1.00 64.78 O HETATM 9127 O HOH A2086 20.074 34.104 -26.211 1.00 52.42 O HETATM 9128 O HOH A2087 16.040 42.567 -19.098 1.00 66.87 O HETATM 9129 O HOH A2088 11.658 45.887 -25.025 1.00 64.85 O HETATM 9130 O HOH A2089 9.770 41.876 -22.947 1.00 57.24 O HETATM 9131 O HOH A2090 14.747 45.995 -20.780 1.00 59.92 O HETATM 9132 O HOH A2091 10.370 50.628 -22.370 1.00 41.99 O HETATM 9133 O HOH A2092 5.274 44.555 -14.235 1.00 41.77 O HETATM 9134 O HOH A2093 -9.213 43.064 -10.194 1.00 45.54 O HETATM 9135 O HOH A2094 -7.066 45.640 -8.187 1.00 53.93 O HETATM 9136 O HOH A2095 -10.879 46.738 -10.110 1.00 61.83 O HETATM 9137 O HOH A2096 -15.180 45.468 -17.938 1.00 58.93 O HETATM 9138 O HOH A2097 -12.036 43.239 -20.046 1.00 53.41 O HETATM 9139 O HOH A2098 -6.646 45.193 -15.389 1.00 55.08 O HETATM 9140 O HOH A2099 -5.881 42.785 -16.589 1.00 61.39 O HETATM 9141 O HOH A2100 -2.588 27.500 -15.873 1.00 67.97 O HETATM 9142 O HOH A2101 -13.907 38.616 -24.120 1.00 71.66 O HETATM 9143 O HOH A2102 1.820 35.228 -39.320 1.00 69.47 O HETATM 9144 O HOH A2103 4.362 29.677 -20.420 1.00 52.23 O HETATM 9145 O HOH A2104 -6.103 28.208 -36.080 1.00 64.13 O HETATM 9146 O HOH A2105 -4.377 29.927 -39.548 1.00 49.96 O HETATM 9147 O HOH A2106 -2.406 30.172 -34.200 1.00 79.90 O HETATM 9148 O HOH A2107 -10.901 32.927 -33.507 1.00 84.33 O HETATM 9149 O HOH A2108 -12.621 37.427 -32.487 1.00 60.79 O HETATM 9150 O HOH A2109 -13.764 55.550 -26.212 1.00 66.27 O HETATM 9151 O HOH A2110 -10.428 60.992 -21.210 1.00 71.04 O HETATM 9152 O HOH A2111 -12.688 62.755 -27.650 1.00 57.27 O HETATM 9153 O HOH A2112 -10.083 56.803 -33.527 1.00 73.24 O HETATM 9154 O HOH A2113 -13.801 55.565 -32.085 1.00 45.71 O HETATM 9155 O HOH A2114 -0.123 45.513 -31.772 1.00 54.24 O HETATM 9156 O HOH A2115 15.075 41.904 -29.633 1.00 57.17 O HETATM 9157 O HOH A2116 8.126 49.731 -23.580 1.00 49.00 O HETATM 9158 O HOH A2117 8.811 54.675 -27.311 1.00 35.88 O HETATM 9159 O HOH A2118 14.558 60.807 -25.400 1.00 56.26 O HETATM 9160 O HOH A2119 5.908 59.615 -27.790 1.00 61.25 O HETATM 9161 O HOH A2120 2.660 65.412 -21.855 1.00 62.19 O HETATM 9162 O HOH A2121 -5.015 74.216 -24.726 1.00 70.48 O HETATM 9163 O HOH A2122 -9.877 69.638 -18.962 1.00 65.14 O HETATM 9164 O HOH A2123 -10.895 63.067 -6.961 1.00 55.06 O HETATM 9165 O HOH A2124 -7.823 63.354 0.469 1.00 59.20 O HETATM 9166 O HOH A2125 -14.319 57.950 1.469 1.00 66.00 O HETATM 9167 O HOH A2126 -11.843 64.324 -2.397 1.00 73.21 O HETATM 9168 O HOH B2001 25.295 34.585 -24.819 1.00 65.17 O HETATM 9169 O HOH B2002 24.034 37.062 -25.567 1.00 50.21 O HETATM 9170 O HOH B2003 22.804 62.854 -10.840 1.00 66.15 O HETATM 9171 O HOH B2004 36.457 44.745 -12.744 1.00 38.30 O HETATM 9172 O HOH B2005 25.367 39.603 -25.402 1.00 65.18 O HETATM 9173 O HOH B2006 39.314 55.168 -16.034 1.00 57.81 O HETATM 9174 O HOH B2007 18.029 50.803 -30.453 1.00 55.57 O HETATM 9175 O HOH B2008 18.732 56.931 -23.004 1.00 59.43 O HETATM 9176 O HOH B2009 12.533 50.940 -26.997 1.00 58.99 O HETATM 9177 O HOH B2010 12.303 57.874 -24.653 1.00 87.32 O HETATM 9178 O HOH B2011 16.155 50.750 -22.297 1.00 74.82 O HETATM 9179 O HOH B2012 9.988 52.467 -20.428 1.00 55.89 O HETATM 9180 O HOH B2013 28.040 58.727 -20.051 1.00 68.81 O HETATM 9181 O HOH B2014 22.204 55.680 -7.013 1.00 60.26 O HETATM 9182 O HOH B2015 35.988 56.791 -15.765 1.00 51.65 O HETATM 9183 O HOH B2016 22.303 59.394 -11.347 1.00 58.84 O HETATM 9184 O HOH B2017 29.901 58.632 -9.011 1.00 66.78 O HETATM 9185 O HOH B2018 33.733 49.302 -10.000 1.00 43.89 O HETATM 9186 O HOH B2019 49.965 41.490 0.477 1.00 67.22 O HETATM 9187 O HOH B2020 52.537 47.112 5.178 1.00 65.52 O HETATM 9188 O HOH B2021 45.609 32.941 10.171 1.00 54.59 O HETATM 9189 O HOH B2022 49.756 34.602 -0.536 1.00117.76 O HETATM 9190 O HOH B2023 51.781 42.208 -5.943 1.00 58.89 O HETATM 9191 O HOH B2024 50.707 37.643 -3.744 1.00 65.85 O HETATM 9192 O HOH B2025 41.367 27.253 -6.335 1.00 58.54 O HETATM 9193 O HOH B2026 30.819 21.393 -14.111 1.00 51.65 O HETATM 9194 O HOH B2027 26.099 23.129 -17.834 1.00 72.88 O HETATM 9195 O HOH B2028 23.188 36.069 -17.040 1.00 46.68 O HETATM 9196 O HOH B2029 26.670 33.512 -17.754 1.00 50.69 O HETATM 9197 O HOH B2030 26.182 36.416 -16.888 1.00 60.84 O HETATM 9198 O HOH B2031 23.978 42.223 -12.021 1.00 40.14 O HETATM 9199 O HOH B2032 33.614 42.318 -10.224 1.00 42.62 O HETATM 9200 O HOH B2033 30.036 49.689 -0.201 1.00 55.80 O HETATM 9201 O HOH B2034 33.909 47.960 8.444 1.00 57.61 O HETATM 9202 O HOH B2035 37.727 41.884 10.068 1.00 55.87 O HETATM 9203 O HOH B2036 44.410 42.977 11.639 1.00 60.70 O HETATM 9204 O HOH B2037 43.482 45.070 6.896 1.00 52.53 O HETATM 9205 O HOH B2038 44.637 39.515 6.998 1.00 60.81 O HETATM 9206 O HOH B2039 52.110 31.677 7.360 1.00 92.11 O HETATM 9207 O HOH B2040 42.734 31.578 10.298 1.00 65.34 O HETATM 9208 O HOH B2041 20.281 41.370 -11.706 1.00 51.65 O HETATM 9209 O HOH B2042 17.483 34.962 -6.335 1.00 62.73 O HETATM 9210 O HOH B2043 19.329 31.809 -12.367 1.00 52.35 O HETATM 9211 O HOH B2044 18.460 29.497 -10.637 1.00 53.85 O HETATM 9212 O HOH B2045 29.181 15.516 -5.320 1.00 63.55 O HETATM 9213 O HOH B2046 39.613 30.451 4.514 1.00 70.83 O HETATM 9214 O HOH B2047 26.069 31.357 14.670 1.00 92.42 O HETATM 9215 O HOH B2048 22.390 36.096 6.950 1.00 63.23 O HETATM 9216 O HOH B2049 26.333 47.161 15.010 1.00 57.14 O HETATM 9217 O HOH B2050 23.735 48.697 -5.206 1.00 58.70 O HETATM 9218 O HOH B2051 24.881 50.576 -8.147 1.00 73.50 O HETATM 9219 O HOH B2052 24.453 44.847 -10.574 1.00 47.63 O HETATM 9220 O HOH B2053 34.407 42.461 -13.008 1.00 49.15 O HETATM 9221 O HOH B2054 24.905 42.061 -25.771 1.00 52.33 O HETATM 9222 O HOH B2055 25.285 50.906 -22.656 1.00109.74 O HETATM 9223 O HOH B2056 32.420 52.526 -21.034 1.00 52.44 O HETATM 9224 O HOH B2057 26.021 43.054 -36.654 1.00 85.99 O HETATM 9225 O HOH B2058 30.458 38.199 -38.150 1.00 70.01 O HETATM 9226 O HOH B2059 26.558 34.920 -29.616 1.00 55.15 O HETATM 9227 O HOH B2060 32.012 36.215 -17.069 1.00 89.60 O HETATM 9228 O HOH B2061 44.707 38.271 -7.269 1.00 51.40 O HETATM 9229 O HOH B2062 44.897 35.710 -14.707 1.00 49.57 O HETATM 9230 O HOH B2063 47.614 38.258 -8.348 1.00 61.07 O HETATM 9231 O HOH B2064 49.562 39.579 -12.985 1.00 52.89 O HETATM 9232 O HOH B2065 50.309 51.896 -10.543 1.00 61.84 O HETATM 9233 O HOH B2066 40.301 53.009 -14.939 1.00 57.63 O HETATM 9234 O HOH B2067 38.786 36.720 -39.424 1.00 65.41 O HETATM 9235 O HOH B2068 40.882 33.663 -36.755 1.00 52.21 O HETATM 9236 O HOH B2069 35.207 58.334 -37.897 1.00 74.21 O HETATM 9237 O HOH B2070 32.215 53.558 -36.874 1.00 81.32 O HETATM 9238 O HOH B2071 24.682 54.696 -26.072 1.00 85.99 O HETATM 9239 O HOH B2072 40.505 58.566 -24.148 1.00 75.55 O HETATM 9240 O HOH B2073 47.949 34.346 -17.292 1.00 50.89 O HETATM 9241 O HOH B2074 53.799 40.039 -17.416 1.00 80.90 O HETATM 9242 O HOH B2075 51.515 26.325 -13.593 1.00 63.68 O HETATM 9243 O HOH B2076 49.409 33.485 -9.402 1.00 62.71 O HETATM 9244 O HOH B2077 50.404 32.003 -11.201 1.00 61.81 O HETATM 9245 O HOH B2078 49.191 25.090 -9.251 1.00 63.20 O HETATM 9246 O HOH B2079 36.307 24.889 -15.302 1.00 51.52 O HETATM 9247 O HOH B2080 44.451 30.019 -22.941 1.00 44.53 O HETATM 9248 O HOH B2081 32.235 29.834 -13.456 1.00 58.24 O HETATM 9249 O HOH B2082 52.408 44.643 -29.257 1.00 55.30 O HETATM 9250 O HOH B2083 52.776 47.027 -30.103 1.00 63.89 O HETATM 9251 O HOH C2001 29.504 42.544 16.400 1.00 55.94 O HETATM 9252 O HOH C2002 27.883 38.289 23.160 1.00 66.22 O HETATM 9253 O HOH C2003 30.333 34.358 15.132 1.00 52.75 O HETATM 9254 O HOH C2004 27.121 38.768 11.692 1.00 41.49 O HETATM 9255 O HOH C2005 30.509 36.797 22.233 1.00 62.37 O HETATM 9256 O HOH C2006 41.179 33.312 26.547 1.00 60.28 O HETATM 9257 O HOH C2007 48.594 45.563 28.519 1.00 70.04 O HETATM 9258 O HOH C2008 38.357 59.736 31.873 1.00 61.85 O HETATM 9259 O HOH C2009 41.095 58.658 25.428 1.00 69.47 O HETATM 9260 O HOH C2010 38.932 52.196 28.336 1.00 72.96 O HETATM 9261 O HOH C2011 31.306 66.853 29.964 1.00 58.70 O HETATM 9262 O HOH C2012 38.519 33.934 15.121 1.00 48.52 O HETATM 9263 O HOH C2013 32.959 43.559 13.079 1.00 42.98 O HETATM 9264 O HOH C2014 32.835 31.831 14.025 1.00 41.57 O HETATM 9265 O HOH C2015 42.910 35.896 16.066 1.00 62.38 O HETATM 9266 O HOH C2016 43.041 45.671 12.545 1.00 53.87 O HETATM 9267 O HOH C2017 39.956 45.998 9.837 1.00 61.47 O HETATM 9268 O HOH C2018 36.359 43.237 13.645 1.00 30.61 O HETATM 9269 O HOH C2019 44.069 41.174 13.631 1.00 45.14 O HETATM 9270 O HOH C2020 43.751 44.704 15.025 1.00 49.52 O HETATM 9271 O HOH C2021 35.513 46.281 27.254 1.00 66.08 O HETATM 9272 O HOH C2022 33.725 49.059 30.878 1.00 61.56 O HETATM 9273 O HOH C2023 31.286 53.026 31.419 1.00 51.76 O HETATM 9274 O HOH C2024 20.935 54.155 29.003 1.00 71.07 O HETATM 9275 O HOH C2025 21.527 59.948 39.267 1.00 78.70 O HETATM 9276 O HOH C2026 23.919 62.862 35.543 1.00 64.10 O HETATM 9277 O HOH C2027 31.880 64.019 29.633 1.00 52.24 O HETATM 9278 O HOH C2028 42.587 55.282 21.649 1.00 54.59 O HETATM 9279 O HOH C2029 33.906 57.244 13.793 1.00115.54 O HETATM 9280 O HOH C2030 44.635 54.719 9.379 1.00 75.46 O HETATM 9281 O HOH C2031 54.769 56.165 9.013 1.00 43.86 O HETATM 9282 O HOH C2032 50.127 80.408 22.125 1.00 62.95 O HETATM 9283 O HOH C2033 44.541 56.183 11.621 1.00 52.98 O HETATM 9284 O HOH C2034 54.524 76.279 14.689 1.00 50.74 O HETATM 9285 O HOH C2035 44.142 49.351 7.267 1.00 77.04 O HETATM 9286 O HOH C2036 34.325 53.008 11.389 1.00 64.81 O HETATM 9287 O HOH C2037 32.337 45.667 11.061 1.00 51.27 O HETATM 9288 O HOH C2038 31.430 52.620 12.928 1.00 51.56 O HETATM 9289 O HOH C2039 29.462 48.889 11.636 1.00 71.62 O HETATM 9290 O HOH C2040 28.518 49.194 14.230 1.00 48.09 O HETATM 9291 O HOH C2041 19.562 48.243 21.791 1.00 69.07 O HETATM 9292 O HOH C2042 44.771 49.495 20.395 1.00 61.81 O HETATM 9293 O HOH C2043 50.846 44.481 18.222 1.00 67.39 O HETATM 9294 O HOH C2044 49.383 47.831 27.247 1.00 52.71 O HETATM 9295 O HOH C2045 72.284 72.101 23.113 1.00 58.25 O HETATM 9296 O HOH C2046 71.253 71.474 11.195 1.00 56.43 O HETATM 9297 O HOH C2047 71.628 46.943 27.284 1.00 82.26 O HETATM 9298 O HOH C2048 71.905 51.814 20.024 1.00 65.11 O HETATM 9299 O HOH C2049 71.447 50.984 22.573 1.00 67.92 O HETATM 9300 O HOH C2050 60.970 50.920 13.955 1.00 36.06 O HETATM 9301 O HOH C2051 56.960 48.779 17.435 1.00 30.62 O HETATM 9302 O HOH C2052 54.956 53.047 10.416 1.00 54.89 O HETATM 9303 O HOH C2053 57.939 58.203 5.797 1.00 65.21 O HETATM 9304 O HOH C2054 58.588 60.707 4.826 1.00 58.20 O HETATM 9305 O HOH C2055 53.053 63.770 8.418 1.00 39.73 O HETATM 9306 O HOH C2056 52.077 69.921 10.511 1.00 41.06 O HETATM 9307 O HOH C2057 43.958 63.374 23.642 1.00 61.26 O HETATM 9308 O HOH C2058 44.150 61.400 27.116 1.00 50.66 O HETATM 9309 O HOH C2059 50.372 66.541 24.581 1.00 41.73 O HETATM 9310 O HOH C2060 50.479 64.340 28.768 1.00 54.70 O HETATM 9311 O HOH C2061 49.596 47.183 13.614 1.00 63.81 O HETATM 9312 O HOH C2062 47.325 53.284 11.583 1.00 50.97 O HETATM 9313 O HOH C2063 37.374 69.864 19.851 1.00 38.83 O HETATM 9314 O HOH C2064 38.521 75.331 18.598 1.00 65.57 O HETATM 9315 O HOH C2065 42.168 79.098 15.938 1.00 78.68 O HETATM 9316 O HOH C2066 36.399 79.078 28.076 1.00 64.41 O HETATM 9317 O HOH C2067 37.644 86.539 23.289 1.00 59.58 O HETATM 9318 O HOH C2068 37.165 69.813 28.180 1.00 53.76 O HETATM 9319 O HOH C2069 41.043 69.644 36.618 1.00 59.19 O HETATM 9320 O HOH C2070 51.696 65.580 31.268 1.00 62.46 O HETATM 9321 O HOH C2071 50.216 67.710 32.112 1.00 78.93 O HETATM 9322 O HOH C2072 52.931 61.422 39.687 1.00 73.43 O HETATM 9323 O HOH C2073 52.236 69.813 27.408 1.00 68.01 O HETATM 9324 O HOH C2074 57.096 69.300 31.471 1.00 35.43 O HETATM 9325 O HOH C2075 47.480 77.622 31.587 1.00 66.70 O HETATM 9326 O HOH C2076 48.032 84.074 28.059 1.00 65.20 O HETATM 9327 O HOH C2077 48.416 81.918 25.769 1.00 72.91 O HETATM 9328 O HOH C2078 50.394 79.027 24.264 1.00 53.57 O HETATM 9329 O HOH C2079 45.463 73.060 31.041 1.00 58.28 O HETATM 9330 O HOH C2080 53.266 77.946 19.693 1.00 54.06 O HETATM 9331 O HOH C2081 51.475 76.601 23.775 1.00 56.21 O HETATM 9332 O HOH C2082 54.163 73.788 16.193 1.00 39.61 O HETATM 9333 O HOH C2083 59.847 62.466 30.447 1.00 46.44 O HETATM 9334 O HOH C2084 73.492 53.634 29.760 1.00 63.09 O HETATM 9335 O HOH C2085 65.670 61.862 33.091 1.00 57.75 O HETATM 9336 O HOH C2086 67.258 57.167 36.006 1.00 79.53 O HETATM 9337 O HOH C2087 69.146 59.262 34.065 1.00 62.35 O HETATM 9338 O HOH C2088 59.059 64.291 32.290 1.00 42.21 O HETATM 9339 O HOH C2089 47.130 72.657 40.343 1.00 66.51 O HETATM 9340 O HOH C2090 63.217 66.178 37.347 1.00 70.23 O HETATM 9341 O HOH C2091 62.791 80.811 24.842 1.00 93.07 O HETATM 9342 O HOH C2092 48.712 79.013 39.861 1.00 51.83 O HETATM 9343 O HOH C2093 53.526 82.829 47.395 1.00 69.31 O HETATM 9344 O HOH C2094 59.622 89.616 38.044 1.00 59.60 O HETATM 9345 O HOH C2095 61.080 80.646 45.229 1.00 70.65 O HETATM 9346 O HOH C2096 56.334 86.202 44.465 1.00 71.07 O HETATM 9347 O HOH C2097 79.268 68.449 30.222 1.00 75.30 O HETATM 9348 O HOH C2098 79.245 68.814 35.421 1.00 59.64 O HETATM 9349 O HOH C2099 76.018 58.713 15.328 1.00 53.39 O HETATM 9350 O HOH C2100 80.025 66.965 20.660 1.00 47.37 O HETATM 9351 O HOH C2101 73.986 65.127 10.326 1.00 48.63 O HETATM 9352 O HOH C2102 75.468 64.035 15.317 1.00 48.14 O HETATM 9353 O HOH C2103 73.807 68.447 11.170 1.00 46.69 O HETATM 9354 O HOH C2104 76.147 66.356 13.786 1.00 49.13 O HETATM 9355 O HOH C2105 74.059 70.016 23.534 1.00 62.74 O HETATM 9356 O HOH C2106 66.513 74.476 24.649 1.00 58.26 O HETATM 9357 O HOH C2107 68.954 72.134 13.737 1.00 46.60 O HETATM 9358 O HOH C2108 64.603 77.350 26.218 1.00 59.15 O HETATM 9359 O HOH C2109 59.722 84.063 17.589 1.00 75.93 O HETATM 9360 O HOH C2110 56.192 73.588 18.056 1.00 37.95 O HETATM 9361 O HOH C2111 59.531 75.347 12.937 1.00 40.59 O HETATM 9362 O HOH C2112 53.987 71.181 12.464 1.00 47.72 O HETATM 9363 O HOH C2113 59.601 68.077 7.101 1.00 67.29 O HETATM 9364 O HOH C2114 64.379 71.504 10.736 1.00 50.93 O HETATM 9365 O HOH C2115 61.313 64.589 6.323 1.00 56.96 O HETATM 9366 O HOH C2116 65.401 64.599 8.070 1.00 39.79 O HETATM 9367 O HOH C2117 73.079 67.486 7.103 1.00 60.62 O HETATM 9368 O HOH C2118 71.944 59.832 5.249 1.00 60.15 O HETATM 9369 O HOH C2119 70.883 53.976 7.844 1.00 36.97 O HETATM 9370 O HOH C2120 65.399 50.348 7.879 1.00 77.66 O HETATM 9371 O HOH C2121 65.638 44.939 14.187 1.00 60.79 O HETATM 9372 O HOH C2122 64.581 46.222 20.462 1.00 50.25 O HETATM 9373 O HOH C2123 61.789 37.991 21.282 1.00 62.36 O HETATM 9374 O HOH C2124 56.403 39.194 24.121 1.00 78.32 O HETATM 9375 O HOH C2125 60.251 42.141 27.040 1.00 64.09 O HETATM 9376 O HOH D2001 3.203 63.883 7.059 1.00 59.63 O HETATM 9377 O HOH D2002 3.901 64.520 4.589 1.00 61.23 O HETATM 9378 O HOH D2003 30.402 100.699 28.676 1.00 60.32 O HETATM 9379 O HOH D2004 28.775 102.421 29.889 1.00 70.65 O HETATM 9380 O HOH D2005 3.293 66.630 9.089 1.00 41.78 O HETATM 9381 O HOH D2006 6.233 63.404 3.482 1.00 52.95 O HETATM 9382 O HOH D2007 35.762 62.838 7.885 1.00 57.71 O HETATM 9383 O HOH D2008 27.332 79.060 7.778 1.00 46.55 O HETATM 9384 O HOH D2009 27.754 93.839 -12.201 1.00 71.39 O HETATM 9385 O HOH D2010 28.147 98.731 28.128 1.00 64.16 O HETATM 9386 O HOH D2011 51.718 89.887 7.494 1.00 86.98 O HETATM 9387 O HOH D2012 59.112 72.863 8.119 1.00 57.55 O HETATM 9388 O HOH D2013 55.762 76.858 12.464 1.00 61.20 O HETATM 9389 O HOH D2014 48.686 76.446 17.606 1.00 46.99 O HETATM 9390 O HOH D2015 45.737 70.304 3.594 1.00 61.99 O HETATM 9391 O HOH D2016 37.114 75.498 -2.628 1.00 58.06 O HETATM 9392 O HOH D2017 29.891 73.461 5.847 1.00 55.56 O HETATM 9393 O HOH D2018 35.253 75.668 -0.378 1.00 50.33 O HETATM 9394 O HOH D2019 27.632 76.145 -1.850 1.00 65.37 O HETATM 9395 O HOH D2020 19.757 76.505 0.510 1.00 84.75 O HETATM 9396 O HOH D2021 15.496 75.222 3.622 1.00 66.08 O HETATM 9397 O HOH D2022 8.188 73.388 4.976 1.00 45.97 O HETATM 9398 O HOH D2023 1.575 70.161 5.861 1.00 59.07 O HETATM 9399 O HOH D2024 2.276 69.184 8.067 1.00 48.20 O HETATM 9400 O HOH D2025 8.345 68.310 9.126 1.00 49.49 O HETATM 9401 O HOH D2026 2.974 68.754 14.765 1.00 57.15 O HETATM 9402 O HOH D2027 0.308 70.858 12.129 1.00 45.55 O HETATM 9403 O HOH D2028 6.263 79.063 10.482 1.00 67.40 O HETATM 9404 O HOH D2029 13.465 82.838 19.939 1.00 49.73 O HETATM 9405 O HOH D2030 16.750 81.794 27.989 1.00 58.23 O HETATM 9406 O HOH D2031 14.703 83.010 27.832 1.00 57.18 O HETATM 9407 O HOH D2032 28.296 77.031 31.396 1.00 52.94 O HETATM 9408 O HOH D2033 33.582 84.409 20.183 1.00 81.17 O HETATM 9409 O HOH D2034 35.124 73.796 16.670 1.00 50.89 O HETATM 9410 O HOH D2035 27.573 76.807 11.415 1.00 51.34 O HETATM 9411 O HOH D2036 8.151 63.816 11.608 1.00 66.48 O HETATM 9412 O HOH D2037 11.626 65.785 6.084 1.00 46.17 O HETATM 9413 O HOH D2038 7.402 63.039 6.666 1.00 47.43 O HETATM 9414 O HOH D2039 -0.106 74.342 9.790 1.00 62.64 O HETATM 9415 O HOH D2040 9.423 72.110 19.546 1.00 31.59 O HETATM 9416 O HOH D2041 2.203 73.899 17.968 1.00 58.25 O HETATM 9417 O HOH D2042 5.679 71.675 22.807 1.00 69.36 O HETATM 9418 O HOH D2043 6.398 61.387 21.364 1.00 44.97 O HETATM 9419 O HOH D2044 6.096 64.459 18.309 1.00 66.78 O HETATM 9420 O HOH D2045 35.688 76.654 24.930 1.00 65.40 O HETATM 9421 O HOH D2046 37.457 72.322 19.833 1.00 44.13 O HETATM 9422 O HOH D2047 33.703 69.182 27.168 1.00 43.80 O HETATM 9423 O HOH D2048 22.204 66.691 34.586 1.00 63.37 O HETATM 9424 O HOH D2049 8.180 69.550 36.028 1.00 65.57 O HETATM 9425 O HOH D2050 11.249 67.264 32.667 1.00 66.19 O HETATM 9426 O HOH D2051 10.833 60.272 29.549 1.00 51.18 O HETATM 9427 O HOH D2052 13.561 64.744 33.537 1.00 46.49 O HETATM 9428 O HOH D2053 13.685 61.114 32.327 1.00 62.93 O HETATM 9429 O HOH D2054 18.442 57.478 20.379 1.00 52.11 O HETATM 9430 O HOH D2055 22.967 59.952 25.323 1.00 47.52 O HETATM 9431 O HOH D2056 20.511 56.530 12.831 1.00 74.84 O HETATM 9432 O HOH D2057 26.613 56.575 12.740 1.00 69.48 O HETATM 9433 O HOH D2058 23.838 52.801 12.878 1.00 61.11 O HETATM 9434 O HOH D2059 33.077 64.595 7.591 1.00 57.52 O HETATM 9435 O HOH D2060 34.159 65.063 12.591 1.00 60.06 O HETATM 9436 O HOH D2061 34.894 72.637 14.179 1.00 44.70 O HETATM 9437 O HOH D2062 28.835 78.952 10.434 1.00 34.46 O HETATM 9438 O HOH D2063 34.466 81.113 19.324 1.00 48.32 O HETATM 9439 O HOH D2064 36.610 72.597 12.155 1.00 38.53 O HETATM 9440 O HOH D2065 38.394 80.828 2.135 1.00 47.99 O HETATM 9441 O HOH D2066 42.423 101.129 12.885 1.00 55.08 O HETATM 9442 O HOH D2067 40.814 92.703 19.908 1.00 67.75 O HETATM 9443 O HOH D2068 30.112 85.114 13.203 1.00 54.05 O HETATM 9444 O HOH D2069 30.192 84.708 16.420 1.00 64.15 O HETATM 9445 O HOH D2070 15.682 80.275 9.254 1.00 49.33 O HETATM 9446 O HOH D2071 15.766 86.607 3.943 1.00 69.58 O HETATM 9447 O HOH D2072 24.986 78.610 5.346 1.00 52.35 O HETATM 9448 O HOH D2073 26.688 75.720 2.054 1.00 73.16 O HETATM 9449 O HOH D2074 23.784 84.166 -4.685 1.00 59.30 O HETATM 9450 O HOH D2075 33.716 104.893 0.875 1.00 64.33 O HETATM 9451 O HOH D2076 39.690 93.900 -3.265 1.00 77.56 O HETATM 9452 O HOH D2077 44.909 95.199 -0.406 1.00 70.53 O HETATM 9453 O HOH D2078 42.884 93.560 -5.987 1.00 52.13 O HETATM 9454 O HOH D2079 51.556 84.501 -0.573 1.00 60.14 O HETATM 9455 O HOH D2080 47.652 80.752 -2.237 1.00 47.85 O HETATM 9456 O HOH D2081 47.969 80.390 4.358 1.00 70.83 O HETATM 9457 O HOH D2082 38.690 80.042 -3.885 1.00 58.32 O HETATM 9458 O HOH D2083 33.528 78.405 -2.640 1.00 64.71 O HETATM 9459 O HOH D2084 38.519 91.711 -5.979 1.00 73.67 O HETATM 9460 O HOH D2085 28.882 85.728 -3.168 1.00 58.99 O HETATM 9461 O HOH D2086 25.495 94.377 -10.665 1.00 73.12 O HETATM 9462 O HOH D2087 19.300 89.232 2.095 1.00 55.55 O HETATM 9463 O HOH D2088 25.047 95.612 -2.484 1.00 49.79 O HETATM 9464 O HOH D2089 13.964 93.200 9.623 1.00 61.96 O HETATM 9465 O HOH D2090 12.777 96.628 7.626 1.00 71.06 O HETATM 9466 O HOH D2091 11.777 89.086 10.761 1.00 64.09 O HETATM 9467 O HOH D2092 18.173 91.196 13.666 1.00 50.23 O HETATM 9468 O HOH D2093 18.302 87.510 15.401 1.00 60.67 O HETATM 9469 O HOH D2094 11.963 84.613 17.833 1.00 48.20 O HETATM 9470 O HOH D2095 16.230 99.986 16.750 1.00 61.17 O HETATM 9471 O HOH D2096 26.809 90.247 25.092 1.00 59.44 O HETATM 9472 O HOH D2097 27.852 90.093 27.548 1.00 62.16 O HETATM 9473 O HOH D2098 28.543 96.499 29.244 1.00 58.42 O HETATM 9474 O HOH D2099 34.700 86.883 23.371 1.00 58.38 O HETATM 9475 O HOH D2100 24.188 106.466 13.284 1.00 79.79 O HETATM 9476 O HOH D2101 26.957 105.194 3.429 1.00 56.73 O HETATM 9477 O HOH D2102 22.016 110.836 3.788 1.00 63.48 O HETATM 9478 O HOH D2103 32.303 98.142 -1.147 1.00 61.26 O HETATM 9479 O HOH E2001 45.621 24.106 2.351 1.00 61.45 O HETATM 9480 O HOH E2002 43.653 24.681 -1.910 1.00 58.98 O HETATM 9481 O HOH F2001 13.973 78.394 31.675 1.00 64.63 O HETATM 9482 O HOH F2002 12.386 77.878 33.551 1.00 59.04 O HETATM 9483 O HOH F2003 3.375 73.797 23.663 1.00 72.14 O HETATM 9484 O HOH F2004 3.888 77.873 21.934 1.00 64.07 O CONECT 8948 8949 8950 8951 CONECT 8949 8948 CONECT 8950 8948 CONECT 8951 8948 CONECT 8964 8977 CONECT 8973 8974 CONECT 8974 8973 8975 8982 CONECT 8975 8974 8976 CONECT 8976 8975 8977 8978 CONECT 8977 8964 8976 CONECT 8978 8976 8979 CONECT 8979 8978 8980 8981 CONECT 8980 8979 CONECT 8981 8979 CONECT 8982 8974 CONECT 8984 8993 CONECT 8993 8984 CONECT 8995 8996 8997 8998 CONECT 8996 8995 CONECT 8997 8995 CONECT 8998 8995 CONECT 9011 9024 CONECT 9020 9021 CONECT 9021 9020 9022 9029 CONECT 9022 9021 9023 CONECT 9023 9022 9024 9025 CONECT 9024 9011 9023 CONECT 9025 9023 9026 CONECT 9026 9025 9027 9028 CONECT 9027 9026 CONECT 9028 9026 CONECT 9029 9021 CONECT 9031 9040 CONECT 9040 9031 MASTER 945 0 6 61 20 0 9 6 9460 6 34 88 END